Document:

seas-ex101_79.htm

 

Exhibit 10.1

EXECUTIVE EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of November 6, 2019, by and between SeaWorld Entertainment, Inc., a Delaware corporation (the “Company”), and Sergio Rivera (the “Executive”).

W I T N E S S E T H :

WHEREAS, the Company desires to employ Executive and to enter into this Agreement embodying the terms of such continued employment, and Executive desires to enter into this Agreement and to be employed by the Company, subject to the terms and provisions of this Agreement.

NOW, THEREFORE, in consideration of the promises and mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are mutually acknowledged, the Company and Executive hereby agree as follows:

Section 1.Definitions. Capitalized terms not otherwise defined in this Agreement shall have the meaning set forth on Appendix A, attached hereto.

Section 2.Acceptance and Term of Employment.

(a)The Company agrees to employ Executive, and Executive agrees to serve the Company, on the terms and conditions set forth herein. The Term of Employment shall commence on November 7, 2019 (or such earlier date on which executive begins employment (the “Commencement Date”)) and continue until the third anniversary of the Commencement Date, unless earlier terminated as provided in Section 6 hereof (the “Term of Employment”); provided that on the third anniversary of the Commencement Date and on each anniversary thereafter (each, an “Extension Date”) the Term of Employment shall be automatically extended for an additional one-year period unless at least 90 days prior to the next Extension Date, the Company or the Executive delivers a written notice to the other party that the Term of Employment shall not be so extended.

(b)Company Nonrenewal. The Company may terminate this Agreement (subject to the continued applicability of certain provisions of this Agreement as provided in Section 21) by delivering to the Executive the written notice of non-renewal as contemplated by Section 2(a) hereof (such termination, a “Company Nonrenewal”). A Company Nonrenewal shall be deemed to constitute Good Reason as of the date of such notice. Section 6 of this Agreement governs any termination of employment by the Company following a Company Nonrenewal.

(c)Executive Nonrenewal. The Executive may terminate this Agreement (subject to the continued applicability of certain provisions of this Agreement as provided in Section 21) by the Executive’s delivery to the Company of the written notice of nonrenewal as contemplated by Section 2(a) hereof (such termination, an “Executive Nonrenewal”). An Executive Nonrenewal may constitute a voluntary termination of employment by the Executive, 

 

 

if the Executive so specifies in the written notice of nonrenewal. If such voluntary termination by the Executive is for Good Reason, then the nonrenewal notice shall include the Notice of Termination.

(d)Notwithstanding the foregoing and for the avoidance of doubt, if the Executive continues employment with the Company following the expiration of the Term of Employment (whether due to a Company Nonrenewal or an Executive Nonrenewal), such employment shall constitute “at will” employment and may be terminated at any time by either party upon written notice and, notwithstanding Section 21 hereof, the provisions of Section 6 shall not apply to such “at-will” employment and no longer be of further force or effect. 

Section 3.Position, Duties, and Responsibilities; Place of Performance.

(a)Position, Duties, and Responsibilities. Beginning on November 11, 2019 and continuing during the Term of Employment, Executive shall be employed and serve as the Chief Executive Officer of the Company (together with such other position or positions consistent with Executive’s title as the Board shall specify from time to time) and shall have such duties and responsibilities commensurate with such title and as the Board may designate from time to time. The Executive shall at all times be the highest ranking officer of the Company and shall report exclusively to the Board and/or such committees thereof as the Board may designate. In addition, the Executive shall be appointed to serve as a director on the Board and, at each annual stockholders meeting during the Term of Employment, shall be nominated for re-election to the Board. If requested by the Company, Executive also agrees to serve as the chief executive officer and/or director of any other member of the Company Group, in each case without additional compensation. The Executive shall be based at the Company’s corporate headquarters in Orlando, Florida. 

(b)Performance. Executive shall devote his full business time, attention, skill, and best efforts to the performance of his duties under this Agreement and shall not engage in any other business or occupation during the Term of Employment, including, without limitation, any activity that (x) conflicts with the interests of the Company or any other member of the Company Group, (y) interferes with the proper and efficient performance of Executive’s duties for the Company, or (z) interferes with Executive’s exercise of judgment in the Company’s best interests. Notwithstanding the foregoing, nothing herein shall preclude Executive from (i) serving as a member of the boards of directors or advisory boards (or their equivalents in the case of a non-corporate entity) of charitable organizations or, with the prior written consent of the Board following a recommendation from the Nominating and Governance Committee of the Board, of non-competing businesses, (ii) engaging in charitable activities and community affairs, and (iii) managing his personal investments and affairs; provided, however, that the activities set out in clauses (i), (ii), and (iii) shall be limited by Executive so as not to materially interfere, individually or in the aggregate, with the performance of his duties and responsibilities hereunder.  For the avoidance of doubt, the Board has consented to Executive’s service as a non-employee outside director on the board of directors of Welltower Inc. (NYSE: WELL).

-2-

 

Section 4.Compensation.

During the Term of Employment, Executive shall be entitled to the following compensation:

(a)Base Salary. Executive shall initially be paid an annualized Base Salary, payable in accordance with the regular payroll practices of the Company, of $600,000. No less frequently than annually, the Executive’s Base Salary shall be reviewed by the Compensation Committee which may (but is not obligated to) adjust such Base Salary in its sole discretion; provided, that Base Salary shall not be decreased.  Any such increased Base Salary shall be the Executive’s “Base Salary” for all purposes under this Agreement.

(b)Annual Bonus. During the Term of Employment, Executive shall be eligible to participate in the annual bonus plan adopted by the Company from time to time (the “Annual Bonus Plan”), pursuant to which Executive shall be eligible to receive an annual incentive bonus award in respect of such fiscal year, and each subsequent year during the Term of Employment (the “Annual Bonus”), with the actual Annual Bonus payable under the Annual Bonus Plan being based upon the level of achievement of Company and/or individual performance objectives for such fiscal year, as established by the Compensation Committee and communicated to Executive. The target Annual Bonus for each such fiscal year (the “Target Annual Bonus”) shall be not less than 200% of Base Salary; provided that, for fiscal year 2019, the Annual Bonus payable, if any, will be pro-rated based on the Commencement Date and portion of the fiscal year Executive is employed with the Company. The Annual Bonus shall otherwise be subject to the terms and conditions of the Annual Bonus Plan, as established by the Compensation Committee and communicated to Executive, with 50% payable in fully vested and unrestricted stock and 50% in cash, unless otherwise determined by the Compensation Committee. Any earned Annual Bonus for a fiscal year shall be paid to the Executive at the same time as annual bonuses are generally payable to other senior executives of the Company, subject to Executive’s continuous employment through the applicable performance period, but in no event later than the 15th day of the third month following the close of such fiscal year, unless the Executive shall elect to defer the receipt of such Annual Bonus pursuant to an arrangement that meets the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”).

(c)Ordinary Course Equity Awards.  During the Term of Employment, Executive will be eligible to participate in the long-term equity incentive plan(s) adopted by the Company from time to time, including without limitation, under the Company’s 2017 Omnibus Incentive Plan, in the normal course and consistent with other senior executives of the Company,  commencing with the equity grant cycle in the earlier of 2023 or the fiscal year following the fiscal year with respect to which any portion of the Sign-On PSUs vest, or such earlier time as the Board may determine, in its sole discretion.

(d)Sign-On Option Grant. As soon as practicable following the Commencement Date, Executive shall receive a one-time grant (the “Sign-On Option Grant”) of options to purchase shares of the Company’s common stock (the “Common Stock”) at an exercise price per share equal to the fair market value of such shares on the date of grant and calculated in accordance with 2017 Omnibus Incentive Plan. The Sign-On Option Grant shall be 

-3-

 

in respect of a number of shares of Common Stock equal to $4,000,000 divided by the 30-day volume weighted average price on the Commencement Date. The Sign-On Option Grant shall fully vest on the third anniversary of the date of grant, or, if earlier, (x) when the first vesting tranche of the Sign-On PSUs vest (as provided in the form of award agreement attached hereto as Exhibit B) or (y) upon a Change in Control (as defined in the Company’s 2017 Omnibus Incentive Plan), provided, in each case, that the Executive remains employed by the Company through such date.  

(e)Sign-On Restricted Stock Unit Grant. As soon as practicable following the Commencement Date, Executive shall receive a one-time grant of restricted stock units (representing one share of Common Stock for each restricted stock unit granted), subject to and in accordance with the applicable terms of the 2017 Omnibus Incentive Plan, with a value on the Commencement Date (using the 30-day volume-weighted average price) equal to:

(i)$1,000,000 (the “Sign-On Time-Vesting RSUs”), which shall vest in three equal annual (33 1/3%) installments over the first three anniversaries of the date of grant, provided the Executive remains employed by the Company through each such date; and

(ii)$7,500,000 (the “Sign-On PSUs”), which shall vest subject to the achievement of adjusted EBITDA and return on invested capital performance metrics (to be determined by the Board and/or Compensation Committee) and in accordance with a form of award agreement substantially similar to the form Performance-Based Restricted Stock Units attached hereto as Exhibit B. 

Section 5.Employee Benefits; Vacation; Reimbursement of Expenses.

(a)During the Term of Employment, Executive shall be entitled to participate in health, insurance, retirement, annual leave and time-off, and other benefits provided generally to similarly situated executive officers of the Company. Executive shall also be entitled to the same number of holidays, vacation days, and sick days, as well as any other benefits, in each case as are generally allowed to similarly situated executive officers of the Company in accordance with the Company policy as in effect from time to time. Nothing contained herein shall be construed to limit the Company’s ability to amend, suspend, or terminate any employee benefit plan or policy at any time without providing Executive notice, and the right to do so is expressly reserved.

(b)Notwithstanding anything to the contrary in Section 5(a), during the Term of Employment, Executive shall be entitled to four (4) weeks of annual paid vacation days, which shall accrue and be usable in accordance with Company policy, as in effect from time to time; provided that for fiscal year 2019, Executive’s annual paid vacation shall be prorated based on the Commencement Date and portion of the fiscal year Executive is employed with the Company.

(c)The Executive shall be entitled to reimbursement for reasonable and necessary out-of-pocket business, entertainment, and travel expenses incurred by the Executive 

-4-

 

in connection with the performance of the Executive's duties hereunder in accordance with the Company's expense reimbursement policies and procedures in effect from time to time.

(d)The Company shall, within thirty days of receipt of an itemized bill, pay directly to Jones Day and Willis Towers Watson the reasonable attorney’s and consultancy fees incurred in negotiating and drafting this Agreement, provided such payments shall not exceed $42,000 in the aggregate. 

Section 6.Termination of Employment.

(a)General. The Term of Employment shall terminate earlier than as provided in Section 2 hereof upon the earliest to occur of (i) Executive’s death, (ii) a termination by reason of a Disability, (iii) a termination by the Company with or without Cause, and (iv) a termination by Executive with or without Good Reason. Upon any termination of Executive’s employment for any reason, except as may otherwise be requested by the Company in writing and agreed upon in writing by Executive, Executive shall resign from any and all directorships, committee memberships, and any other positions Executive holds with the Company or any other member of the Company Group. Notwithstanding anything herein to the contrary, other than the requirements of Section 12 hereof, the payment (or commencement of a series of payments) hereunder of any nonqualified deferred compensation (within the meaning of Section 409A of the Code) upon a termination of employment shall be delayed until such time as Executive has also undergone a “separation from service” as defined in Treas. Reg. 1.409A-1(h), at which time such nonqualified deferred compensation (calculated as of the date of Executive’s termination of employment hereunder) shall be paid (or commence to be paid) to Executive on the schedule set forth in this Section 6 as if Executive had undergone such termination of employment (under the same circumstances) on the date of his ultimate “separation from service.”

(b)Termination Due to Death or Disability. Executive’s employment shall terminate automatically upon his death. The Company may terminate Executive’s employment immediately upon the occurrence of a Disability, such termination to be effective upon Executive’s receipt of written notice of such termination. Upon Executive’s death or in the event that Executive’s employment is terminated due to his Disability, Executive or his estate or his beneficiaries, as the case may be, shall be entitled to:

(i)The Accrued Obligations; and

(ii)An amount, if any, equal to (A) the Annual Bonus that Executive would otherwise have been entitled to receive under the Annual Bonus Plan (subject to and based on actual achievement of applicable business performance objectives and assuming full achievement of any individual or discretionary performance objectives) had no such termination occurred, multiplied by (B) a fraction, the numerator of which is the number of days elapsed from the commencement of such fiscal year through the date of such termination and the denominator of which is 365 (such amount, if any, the “Pro Rata Bonus”), which amount shall be paid at such time annual bonuses are paid to other senior executives of the Company, but in no event later than the 15th day of the third month following the last day of the fiscal year in which such termination occurred.

-5-

 

Following Executive’s death or a termination of Executive’s employment by reason of a Disability, except as set forth in this Section 6(b), Executive shall have no further rights to any compensation or any other benefits under this Agreement.

(c)Termination by the Company for Cause.

(i)The Company may terminate Executive’s employment at any time for Cause, effective upon Executive’s receipt of written notice of such termination.

(ii)In the event that the Company terminates Executive’s employment for Cause, Executive shall be entitled only to the Accrued Obligations. Following such termination of Executive’s employment for Cause, except as set forth in this Section 6(c)(ii), Executive shall have no further rights to any compensation or any other benefits under this Agreement.

(d)Termination by the Company without Cause.  The Company may terminate Executive’s employment without Cause, effective upon Executive’s receipt of written notice of such termination. In the event that Executive’s employment is terminated by the Company without Cause (other than due to death or Disability), Executive shall be entitled to:

(i)The Accrued Obligations;

(ii)The Pro Rata Bonus, which amount shall be paid at such time annual bonuses are paid to other senior executives of the Company, but in no event later than the 15th day of the third month following the last day of the fiscal year in which such termination occurred;

(iii)An amount equal to the Severance Factor multiplied by the sum of (x) Base Salary and (y) the greater of (A) the Annual Bonus earned in respect of the fiscal year prior to the fiscal year of termination(not to exceed the Target Annual Bonus) and (B) 100% of Base Salary, such amount to be paid in a lump sum within 15 days following the date of termination;

(iv)Full accelerated vesting and immediate lapse of restrictions on each of the Sign-On Time-Vesting RSUs; and

(v)Subject to Executive’s election of COBRA continuation coverage under the Company’s group health plan, payment, on the first regularly scheduled payroll date of each month during the Severance Term, of an amount equal to the difference between the monthly COBRA premium cost and the monthly contribution paid by active employees for the same coverage; provided, that the payments described in this clause (v) shall cease earlier in the event that Executive becomes eligible to receive any health benefits as a result of subsequent employment or service.

Notwithstanding the foregoing, the payments and benefits described in clauses (ii) and (v) above shall immediately terminate, and the Company shall have no further obligations to Executive 

-6-

 

with respect thereto, in the event that Executive breaches any provision of the  Restrictive Covenants contained in Appendix B attached hereto. Following such termination of Executive’s employment by the Company without Cause, except as set forth in this Section 6(d) and Section 14, Executive shall have no further rights to any compensation or any other benefits under this Agreement. 

(e)Termination by Executive with Good Reason. Executive may terminate Executive’s employment with Good Reason by providing the Company fifteen (15) days’ written notice setting forth in reasonable specificity the event that constitutes Good Reason, which written notice, to be effective, must be provided to the Company within sixty (60) days of the Executive’s knowledge (whether actual or constructive, including, without limitation, knowledge that Executive would have reasonably obtained after making due and appropriate inquiry) of such event. During such fifteen (15) day notice period, the Company shall have a cure right (if curable), and if not cured within such period, Executive’s termination will be effective upon the expiration of such cure period, and Executive shall be entitled to the same payments and benefits as provided in Section 6(d) hereof for a termination by the Company without Cause, subject to the same conditions on payment and benefits as described in Section 6(d) hereof. Following such termination of Executive’s employment by Executive with Good Reason, except as set forth in this Section 6(e) and Section 14, Executive shall have no further rights to any compensation or any other benefits under this Agreement. A Company Nonrenewal shall constitute a “Good Reason” trigger and if Executive resigns for Good Reason following a Company Nonrenewal, Executive shall (subject to the satisfaction of any applicable performance objectives) be entitled to receive the benefit of the full value of the Sign-On PSUs (subject to the achievement of the performance metrics) and the Sign-On Option Grant, in each case, to the extent the performance or vesting period would be completed by (or within 31 days of) the end of the fiscal year in which such Company Nonrenewal occurred, as though Executive had remained employed through the end of such performance or vesting period.

(f)Termination by Executive without Good Reason. Executive may terminate his employment without Good Reason by providing the Company thirty (30) days’ written notice of such termination. In the event of a termination of employment by Executive under this Section 6(f), Executive shall be entitled only to the Accrued Obligations. In the event of termination of Executive’s employment under this Section 6(f), the Company may, in its sole and absolute discretion, by written notice accelerate such date of termination without changing the characterization of such termination as a termination by Executive without Good Reason. Following such termination of Executive’s employment by Executive without Good Reason, except as set forth in this Section 6(f) and Section 14, Executive shall have no further rights to any compensation or any other benefits under this Agreement.

(g)Release. Notwithstanding any provision herein to the contrary, the payment of any amount or provision of any benefit pursuant to subsection (d) or (e) of this Section 6 (other than the Accrued Obligations) (collectively, the “Severance Benefits”) shall be conditioned upon Executive’s execution, delivery to the Company, and non-revocation of the Release of Claims (and the expiration of any revocation period contained in such Release of Claims) within sixty (60) days following the date of Executive’s termination of employment hereunder. If Executive fails to execute the Release of Claims in such a timely manner so as to permit any revocation period to expire prior to the end of such sixty (60) day period, or timely 

-7-

 

revokes his acceptance of such release following its execution, Executive shall not be entitled to any of the Severance Benefits. Further, to the extent that any of the Severance Benefits constitutes “nonqualified deferred compensation” for purposes of Section 409A of the Code, any payment of any amount or provision of any benefit otherwise scheduled to occur prior to the sixtieth (60th) day following the date of Executive’s termination of employment hereunder, but for the condition on executing the Release of Claims as set forth herein, shall not be made until the first regularly scheduled payroll date following such sixtieth (60th) day, after which any remaining Severance Benefits shall thereafter be provided to Executive according to the applicable schedule set forth herein.

(h)Notice of Termination. Any written notice of termination given under Section 6 of this Agreement shall be provided to the other party in accordance with Section 18 of this Agreement. In addition, any written notice pertaining to a termination by the Company for Cause or by Executive for Good Reason shall meet the requirements of a Notice of Termination (as defined in this paragraph). For purposes of this Agreement, a “Notice of Termination” means a written notice which (i) indicates the specific termination provision in this Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated and (iii) the Date of Termination (as defined below).

(i)Date of Termination. “Date of Termination” means (i) if the Executive’s employment is terminated by the Company for Cause, the date of expiration of the cure period set forth in the definition of “Cause”, (ii) if the Executive’s employment is terminated by the Executive for Good Reason, the date of expiration of the cure period specified in Section 6(e), (iii) if the Executive’s employment is terminated by the Company other than for Cause or Disability, the date on which the Company notifies the Executive of such termination or such later date specified by the Company, (iv) if the Executive voluntarily resigns without Good Reason, the date at least thirty (30) days after the Executive notifies the Company, subject to the Company’s right to accelerate such date of termination without changing the characterization of such termination as a termination by the Executive without Good Reason as provided in Section 6(f), (v) if the Executive’s employment is terminated by reason of death, the date of death of the Executive, or (vi) if the Executive’s employment is terminated by the Company due to Disability, the date specified by the Company.

Section 7.Certain Payments.

(a)Notwithstanding any other provision of this Agreement or any other plan, arrangement or agreement to the contrary, in the event that any payment or benefit received or to be received by the Executive pursuant to this Agreement or otherwise (“Payments”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”) and (ii) but for this section, be subject to the excise tax imposed by Section 4999 of the Code, any successor provisions, or any comparable federal, state, local or foreign excise tax (“Excise Tax”), then, subject to the provisions of this Section 7, such Payments shall be either (A) provided in full pursuant to the terms of this Agreement or any other applicable agreement, or (B) provided as to such lesser extent which would result in no portion of such Payments being subject to the Excise Tax (“Reduced Amount”), whichever of the foregoing amounts, taking into account the applicable federal, state, local and foreign 

-8-

 

income, employment and other taxes and the Excise Tax (including, without limitation, any interest or penalties on such taxes), results in the receipt by the Executive, on an after-tax basis, of the greatest amount of payments and benefits provided for hereunder or otherwise, notwithstanding that all or some portion of such Payments may be subject to the Excise Tax.

(b)Unless the Company and the Executive otherwise agree in writing, any determination required under this Section 7 shall be made by an independent advisor designated by the Company and reasonably acceptable to the Executive (“Independent Advisor”), whose determination shall be conclusive and binding upon the Executive and the Company for all purposes; provided that each party may have a reasonable opportunity to challenge such determinations. For purposes of making the calculations required under this Section, Independent Advisor shall make use of reasonable mitigation techniques, including making reasonable exclusions for certain amounts as consideration for applicable restrictive covenants, and may make reasonable assumptions and approximations concerning applicable taxes and rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code; provided that Independent Advisor shall assume that the Executive pays all taxes at the highest marginal rate. The Company and the Executive shall furnish to Independent Advisor such information and documents as Independent Advisor may reasonably request in order to make a determination under this Section. The Company shall bear all costs that Independent Advisor may incur in connection with any calculations contemplated by this Section and shall use its best efforts to defend the calculations of the Independent Advisor if they are challenged by the Internal Revenue Service (“IRS”). The reduction of the Payments payable hereunder, if applicable, shall be made by first reducing the cash payments under Section 6(d)(ii), second by reducing the Pro Rata Bonus, third by reducing COBRA reimbursement under Section 6(d)(v) and lastly by reducing any other Payments in a manner determined by the Company, in consultation with the Executive.

(c)If, notwithstanding any reduction described in Section 7 (or in the absence of any such reduction), the IRS determines that the Executive is liable for the Excise Tax as a result of the receipt of one or more Payments, then the Executive shall be obligated to surrender or pay back to the Company, within 120 days after a final IRS determination, an amount of such payments or benefits equal to the “Repayment Amount.” The Repayment Amount with respect to such Payments shall be the smallest such amount, if any, as shall be required to be surrendered or paid to the Company so that the Executive’s net proceeds with respect to such Payments (after taking into account the payment of the excise tax imposed on such Payments) shall be maximized. Notwithstanding the foregoing, the Repayment Amount with respect to such Payments shall be zero if a Repayment Amount of more than zero would not eliminate the Excise Tax imposed on such Payments or if a Repayment Amount of more than zero would not maximize the net amount received by the Executive from the Payments. If the Excise Tax is not eliminated pursuant to this Section 7, the Executive shall pay the Excise Tax.

Section 8.Restrictive Covenants.

Executive acknowledges and recognizes the highly competitive nature of the businesses of the Company Group and accordingly agrees, as a condition of Executive’s continued employment with the Company, to be bound by and comply with the Restrictive Covenants contained in Appendix B attached hereto and incorporated by reference herein. 

-9-

 

Executive acknowledges and agrees that the Company’s remedies at law for a breach or threatened breach of any of the provisions of Section 1 of Appendix B (or a material breach or material threatened breach of any of the provisions of Section 2 of Appendix B of this Agreement) would be inadequate and the Company would suffer irreparable damages as a result of such breach or threatened breach. In recognition of this fact, Executive agrees that, in the event of such a breach or threatened breach, in addition to any remedies at law and in addition to cessation of payments described in the last paragraph of Section 6(d), the Company, without posting any bond, shall be entitled to obtain equitable relief in the form of specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available. For the avoidance of doubt, the Restrictive Covenants contained in Appendix B shall be in addition to, and not in lieu of, any other similar restrictive covenants contained in any other agreement between Executive and any member of the Company Group. Notwithstanding the foregoing and for the avoidance of doubt, the provisions of Appendix B will survive a termination of this Agreement due to a non-renewal by the Company or the Executive.

Section 9.Representations and Warranties of Executive. Executive represents and warrants to the Company that:

(a)Executive has had the opportunity to consult with, and is represented by, his own tax and legal advisor(s) in connection with the negotiation and preparation of this Agreement;

(b)Executive is entering into this Agreement voluntarily and that his employment hereunder and compliance with the terms and conditions hereof will not conflict with or result in the breach by him of any agreement to which he is a party or by which he may be bound;

(c)Executive has not violated, and in connection with his employment with the Company will not violate, any non-solicitation, non-competition, or other similar covenant or agreement of a prior employer by which he is or may be bound; and

(d)in connection with his employment with the Company, Executive will not use any confidential or proprietary information he may have obtained in connection with employment with any prior employer.

Section 10.Taxes.

The Company may withhold from any payments made under this Agreement all applicable taxes, including but not limited to income, employment, and social insurance taxes, as shall be required by law. Executive acknowledges and represents that the Company has not provided any tax advice to him in connection with this Agreement and that he has been advised by the Company to seek tax advice from his own tax advisors regarding this Agreement and payments that may be made to him pursuant to this Agreement, including specifically, the application of the provisions of Section 409A of the Code to such payments.

-10-

 

Section 11.Set Off; Mitigation.

The Company’s obligation to pay Executive the amounts provided and to make the arrangements provided hereunder shall not be subject to set-off, counterclaim, or recoupment of amounts owed by Executive to the Company or its affiliates. Executive shall not be required to mitigate the amount of any payment provided pursuant to this Agreement by seeking other employment or otherwise, and except as provided in Section 6(b)(iii) and Section 6(d)(v) hereof, the amount of any payment provided for pursuant to this Agreement shall not be reduced by any compensation earned as a result of Executive’s other employment or otherwise.

Section 12.Additional Section 409A Provisions. Notwithstanding any provision in this Agreement to the contrary:

(a)Any payment otherwise required to be made hereunder to Executive at any date as a result of the termination of Executive’s employment shall be delayed for such period of time as may be necessary to meet the requirements of Section 409A(a)(2)(B)(i) of the Code (the “Delay Period”). On the first business day following the expiration of the Delay Period, Executive shall be paid, in a single cash lump sum, an amount equal to the aggregate amount of all payments delayed pursuant to the preceding sentence, and any remaining payments not so delayed shall continue to be paid pursuant to the payment schedule set forth herein.

(b)Each payment in a series of payments hereunder shall be deemed to be a separate payment for purposes of Section 409A of the Code.

(c)To the extent that any right to reimbursement of expenses or payment of any benefit in-kind under this Agreement constitutes nonqualified deferred compensation (within the meaning of Section 409A of the Code), (i) any such expense reimbursement shall be made by the Company no later than the last day of the taxable year following the taxable year in which such expense was incurred by Executive, (ii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (iii) the amount of expenses eligible for reimbursement or in-kind benefits provided during any taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits to be provided in any other taxable year; provided, that the foregoing clause shall not be violated with regard to expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement is in effect.

(d)While the payments and benefits provided hereunder are intended to be structured in a manner to avoid the implication of any penalty taxes under Section 409A of the Code, in no event whatsoever shall any member of the Company Group be liable for any additional tax, interest, or penalties that may be imposed on Executive as a result of Section 409A of the Code or any damages for failing to comply with Section 409A of the Code (other than for withholding obligations or other obligations applicable to employers, if any, under Section 409A of the Code). If any provision of this Agreement (or of any award of compensation, including equity compensation or benefits) would cause Executive to incur any additional tax or interest under Section 409A of the Code, the Company shall, after consulting with and receiving the approval of Executive, reform such provision in a manner intended to avoid the incurrence by Executive of any such additional tax or interest.

-11-

 

Section 13.Successors and Assigns; No Third-Party Beneficiaries.

(a)The Company. This Agreement shall inure to the benefit of the Company and its respective successors and assigns. Except as provided below, neither this Agreement nor any of the rights, obligations, or interests arising hereunder may be assigned by the Company to a Person (other than another member of the Company Group, or its or their respective successors) without Executive’s prior written consent (which shall not be unreasonably withheld, delayed, or conditioned); provided, however, that in the event of a sale of all or substantially all of the assets of the Company or any direct or indirect division or subsidiary thereof to which Executive’s employment primarily relates, the Company may provide that this Agreement will be assigned to, and assumed by, the acquiror of such assets, division or subsidiary, as applicable, without Executive’s consent.  The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to assume this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.

(b)Executive. Executive’s rights and obligations under this Agreement shall not be transferable by Executive by assignment or otherwise, without the prior written consent of the Company; provided, however, that if Executive shall die, all amounts then payable to Executive hereunder shall be paid in accordance with the terms of this Agreement to Executive’s devisee, legatee, or other designee, or if there be no such designee, to Executive’s estate.

(c)No Third-Party Beneficiaries. Except as otherwise set forth in Section 6(b) or Section 13(b) hereof, nothing expressed or referred to in this Agreement will be construed to give any Person other than the Company, the other members of the Company Group, and Executive any legal or equitable right, remedy, or claim under or with respect to this Agreement or any provision of this Agreement.

Section 14.Disputes; Legal Fees.

Any dispute or controversy arising under or in connection with this Agreement shall be settled exclusively in the courts of the State of Florida. The parties hereto irrevocably agree to submit to the jurisdiction and venue of the courts of the State of Florida in any action or proceeding brought with respect to or in connection with this Agreement. In the event of any material contest or dispute relating to this Agreement or the termination of the Executive’s employment hereunder, each of the parties shall bear its own costs and expenses.

Section 15.Waiver and Amendments.

Any waiver, alteration, amendment, or modification of any of the terms of this Agreement shall be valid only if made in writing and signed by each of the parties hereto; provided, however, that any such waiver, alteration, amendment, or modification must be consented to on the Company’s behalf by the Compensation Committee and the Board. No waiver by either of the parties hereto of their rights hereunder shall be deemed to constitute a waiver with respect to any subsequent occurrences or transactions hereunder unless such waiver specifically states that it is to be construed as a continuing waiver.

-12-

 

Section 16.Severability.

If any covenants or such other provisions of this Agreement are found to be invalid or unenforceable by a final determination of a court of competent jurisdiction, (a) the remaining terms and provisions hereof shall be unimpaired, and (b) the invalid or unenforceable term or provision hereof shall be deemed replaced by a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision hereof.

Section 17.Governing Law; Waiver of Jury Trial.

THIS AGREEMENT IS GOVERNED BY AND IS TO BE CONSTRUED UNDER THE LAWS OF THE STATE OF FLORIDA WITHOUT GIVING EFFECT TO THE PRINCIPLES OF CONFLICTS OF LAWS. EACH PARTY TO THIS AGREEMENT ALSO HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS AGREEMENT.

Section 18.Notices.

(a)Place of Delivery. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or delivered to the party for whom or which it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided; provided, that unless and until some other address be so designated, all notices and communications by Executive to the Company shall be mailed or delivered to the Company at its principal executive office to the attention of the General Counsel, and all notices and communications by the Company to Executive may be given to Executive personally or may be mailed to Executive at Executive’s last known address, as reflected in the Company’s records.

(b)Date of Delivery. Any notice so addressed shall be deemed to be given (i) if delivered by hand, on the date of such delivery, (ii) if mailed by courier or by overnight mail, on the first business day following the date of such mailing, and (iii) if mailed by registered or certified mail, on the third business day after the date of such mailing.

Section 19.Section Headings.

The headings of the sections and subsections of this Agreement are inserted for convenience only and shall not be deemed to constitute a part thereof or affect the meaning or interpretation of this Agreement or of any term or provision hereof.

Section 20.Entire Agreement.

This Agreement, together with any exhibits and appendices attached hereto and any equity award grants referenced herein to be made by the Company to the Executive, constitutes the entire understanding and agreement of the parties hereto regarding the employment of Executive. This Agreement supersedes all prior negotiations, discussions, 

-13-

 

correspondence, communications, understandings, and agreements between the parties relating to the subject matter of this Agreement.

Section 21.Survival of Operative Sections.

Upon any termination of Executive’s employment, the provisions of Section 6 through Section 21 of this Agreement (together with any related definitions set forth in Section 1 hereof) shall survive to the extent necessary to give effect to the provisions thereof. 

Section 22.Counterparts.

This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument. The execution of this Agreement may be by actual or facsimile signature.

***

[Signatures to appear on the following page.]

 

-14-

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.

SEAWORLD ENTERTAINMENT, INC.

 

/s/ G. Anthony (Tony) Taylor

By: G. Anthony (Tony) Taylor

Title: Chief Legal Officer, General Counsel and Corporate Secretary

 

 

EXECUTIVE

 

/s/ Sergio Rivera

Sergio Rivera

 

 

 

 

 

 

APPENDIX A

Definitions

(a)“Accrued Obligations” shall mean (i) all accrued but unpaid Base Salary and unused vacation through the date of termination of Executive’s employment, (ii) any accrued but unpaid Annual Bonus that is required to be paid in accordance with the terms of the Annual Bonus Plan in respect of any prior fiscal year, (iii) any benefits provided under the Company’s employee benefit plans or any incentive plans upon a termination of employment, including rights with respect to Company equity (or equity derivatives), in accordance with the terms contained therein and (iv) reimbursement for unreimbursed business expenses incurred by Executive.  The amounts provided under clauses (i), (ii) and (iv) shall be paid to Executive within fourteen (14) business days following the Executive’s Date of Termination.

(b)“Agreement” shall have the meaning set forth in the preamble hereto.

(c)“Annual Bonus” shall have the meaning set forth in Section 4(b) hereof.

(d)“Base Salary” shall mean the salary provided for in Section 4(a).

(e)“Board” shall mean the Board of Directors of the Company.

(f)“Cause” shall mean (i) Executive’s act(s) of gross negligence or willful misconduct in the course of Executive’s employment hereunder, (ii) willful failure or refusal by Executive (or Executive’s inability, as a result of circumstances described in clause (v) of this definition) to perform in any material respect his duties or responsibilities or any lawful written instructions by the Board that is incurable or not cured to the Board’s satisfaction within three (3) days after written notice thereof to Executive, (iii) misappropriation (or attempted misappropriation) by Executive of any assets or business opportunities of the Company or any other member of the Company Group, (iv) embezzlement, dishonesty or fraud committed (or attempted) by Executive, or at his direction, (v)  Executive’s commission of, indictment for, or pleading “guilty” or “no contest” to, (x) a felony or (y) any other criminal charge involving moral turpitude, (vi)  any violation by Executive of the policies of the Company, including but not limited to those relating to sexual harassment or business conduct, and those otherwise set forth in the manuals or statements of policy of the Company, (vii) Executive’s material breach of this Agreement that is incurable or not cured to the Board’s satisfaction within three (3) days after written notice thereof to Executive or (viii) Executive’s material breach of the Restrictive Covenants contained in Appendix B or any other similar restrictive covenants contained in any other agreement between Executive and any member of the Company Group.  A termination of employment of the Executive shall not be deemed to be for Cause unless and until the Board has taken an action by the affirmative vote or consent of not less than a majority of the entire membership of the Board (not including the Executive) in which the Board identifies the conduct of Executive constituting grounds for Cause, as described in one or more of the clauses of the definition of Cause, and specifies the particulars thereof in reasonable detail. 

 

 

(g)“Change in Control” shall have the meaning assigned to such term in the SeaWorld Entertainment, Inc. 2017 Omnibus Incentive Plan, as amended from time to time (or any successor plan).

(h)“Code” shall mean the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder.

(i)“Company” shall have the meaning set forth in the preamble hereto.

(j)“Company Group” shall mean the Company together with any of its direct or indirect subsidiaries.

(k)“Compensation Committee” shall mean the committee of the Board designated to make compensation decisions relating to senior executive officers of the Company Group.

(l)“Delay Period” shall have the meaning set forth in Section 12 hereof.

(m)“Disability” shall mean any physical or mental disability or infirmity of Executive that prevents, with reasonable accommodation to the extent required by applicable law, the performance of Executive’s duties for a period of (i) one hundred twenty (120) consecutive days or (ii) one hundred eighty (180) non-consecutive days during any twelve (12) month period. Any question as to the existence, extent, or potentiality of Executive’s Disability upon which Executive and the Company cannot agree shall be determined by a qualified, independent physician selected by the Company and approved by Executive (which approval shall not be unreasonably withheld). The determination of any such physician shall be final and conclusive for all purposes of this Agreement.

(n)“Executive” shall have the meaning set forth in the preamble hereto.

(o)“Excise Tax” shall have the meaning set forth in Section 7 hereto.

(p)“Good Reason” shall mean, without Executive’s consent, (i) a material diminution in Executive’s title, duties, or responsibilities as set forth in Section 3 hereof, (ii) a material reduction in Executive’s Base Salary or Target Annual Bonus opportunity (other than an across the board reduction, applicable to all similarly situated senior executives of the Company), (iii) a material breach by the Company of any material provision of this Agreement, (iv) the relocation of Executive’s principal place of employment by more than fifty (50) miles from the Company’s headquarters in Orlando, Florida, (v) a Company Nonrenewal or (vi) following a Change in Control, the Company’s failure to provide annual long-term equity incentive grants with a grant date fair value of at least $3 million.  Notwithstanding the foregoing, during the Term of Employment, in the event that the Board reasonably believes that Executive may have engaged in conduct that could constitute Cause hereunder or may be experiencing a Disability, the Board may, in its sole and absolute discretion, upon reasonable written notice to Executive, suspend Executive from performing his duties hereunder, and in no event shall any such suspension constitute an event pursuant to which Executive may terminate employment with Good Reason or otherwise constitute a breach hereunder; provided, that no 

-2-

 

such suspension shall alter the Company’s obligations under this Agreement during such period of suspension.

(q)“Independent Advisor” shall have the meaning set forth in Section 7 hereto.

(r)“IRS” shall have the meaning set forth in Section 7 hereto.

(s)“Notice of Termination” shall have the meaning set forth in Section 6(h) hereto.

(t)“Payments” shall have the meaning set forth in Section 7 hereto.

(u)“Person” shall mean any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock company, trust (charitable or non-charitable), unincorporated organization, or other form of business entity.

(v)“Pro Rata Bonus” shall have the meaning set forth in Section 6(b) hereof.

(w)“Reduced Amount” shall have the meaning set forth in Section 7 hereto.

(x)“Release of Claims” shall mean the Release of Claims in substantially the same form attached hereto as Exhibit A (as the same may be revised from time to time by the Company upon the advice of counsel).

(y)“Repayment Amount” shall have the meaning set forth in Section 7 hereto.

(z)“Restrictive Covenants” shall mean the restrictive covenants contained in Appendix B attached hereto.

(aa)“Severance Benefits” shall have the meaning set forth in Section 6(g) hereof.

(bb)“Severance Factor” shall mean, during the Term of Employment (including any mutually agreed extension of such Term of Employment):

	
 
	
a.
	
In the case of a termination of Executive’s employment by the Company without Cause (other than by reason of death or Disability) or by Executive for Good Reason, in either case, during the twelve (12) month period immediately following the occurrence of a Change in Control, 3.0, and 

	
 
	
b.
	
In the case of any other termination of Executive’s employment by the Company without Cause (other than by reason of death or Disability) or by Executive for Good Reason not described in the preceding clause (a) of this definition, 2.0.

-3-

 

(cc)“Severance Term” shall mean the number of months following Executive’s termination by the Company without Cause (other than by reason of death or Disability) or by Executive for Good Reason equal to the product of (a) the Severance Factor multiplied by (b) twelve (12) months.

(dd)“Target Annual Bonus” shall have the meaning set forth in Section 4(b) hereof.

(ee)“Term of Employment” shall mean the period specified in Section 2 hereof.

 

-4-

 

APPENDIX B

Restrictive Covenants

	
1.
	
Non-Competition; Non-Solicitation.

	
(a)
	
Executive acknowledges and recognizes the highly competitive nature of the businesses of the Company and its affiliates and accordingly agrees as follows:

	
(i)
	
During Executive’s employment with the Company or its subsidiaries (the “Employment Term”) and for a period of the greater of (x) two years following the date Executive ceases to be employed by the Company or its subsidiaries and (y) the Severance Term (the “Restricted Period”), Executive will not, whether on Executive’s own behalf or on behalf of or in conjunction with any person, firm, partnership, joint venture, association, corporation or other business organization, entity or enterprise whatsoever (“Person”), directly or indirectly solicit or assist in soliciting in competition with the Restricted Group in the Business, the business of any then current or prospective client or customer with whom Executive (or his direct reports) had personal contact or dealings on behalf of the Company during the one-year period preceding Executive’s termination of employment.

	
(ii)
	
During the Restricted Period, Executive will not directly or indirectly:

	
 
	
(A)
	
engage in the Business in any geographical area that is within 300 miles of any geographical area where the Restricted Group engages in the Business, including the greater metropolitan areas of Orlando, Florida, Tampa, Florida, San Diego, California, Chula Vista, California, San Antonio, Texas, Williamsburg, Virginia and Philadelphia/Langhorne, Pennsylvania;

	
 
	
(B)
	
enter the employ of, or render any services to, a Core Competitor, except where such employment or services do not relate in any manner to the Business;

	
 
	
(C)
	
acquire a financial interest in, or otherwise become actively involved with, any Person engaged in the Business, directly or indirectly, as an individual, partner, shareholder, officer, director, principal, agent, trustee or consultant; or  

	
 
	
(D)
	
intentionally and adversely interfere with, or attempt to adversely interfere with, business relationships between the members of the Restricted Group and any of their clients, customers, suppliers, partners, members or investors.

	
(iii)
	
Notwithstanding anything to the contrary in this Appendix B, Executive may, directly or indirectly own, solely as an investment, securities of any Person engaged in a Business (including, without limitation, a Core Competitor) which are publicly traded on a national or regional stock exchange or on the over-the-counter market if Executive (i) is not a controlling person of, or a member of a group which controls, such 

 

 

		
person and (ii) does not, directly or indirectly, own 2% or more of any class of securities of such Person.

	
(iv)
	
During the Restricted Period, Executive will not, whether on Executive’s own behalf or on behalf of or in conjunction with any Person, directly or indirectly:

	
 
	
(A)
	
solicit or encourage any employee of the Restricted Group to leave the employment of the Restricted Group;

	
 
	
(B)
	
hire any executive-level employee who was employed by the Restricted Group as of the date of Executive’s termination of employment with the Company or who left the employment of the Restricted Group coincident with, or within one year prior to or after, the termination of Executive’s employment with the Company; or

	
 
	
(C)
	
encourage any material consultant of the Restricted Group to cease working with the Restricted Group.

	
(ii)
	
For purposes of this Appendix B:

	
 
	
(A)
	
“Restricted Group” shall mean, collectively, the Company and its subsidiaries and, to the extent engaged in the Business, their respective affiliates.

	
 
	
(B)
	
“Business” shall mean, collectively, the location-based entertainment business and the entertainment and theme park business.  

	
 
	
(C)
	
“Core Competitor” shall mean Walt Disney Parks and Resorts, Universal Parks and Resorts, Six Flags, Inc., Cedar Fair Entertainment Company and Merlin Entertainments Group Ltd., Herschend Family Entertainment, Parques Reunidos and each of their respective affiliates.

	
(c)
	
Non-Disparagement. Executive will not at any time (whether during or after Executive’s Employment Term) make public statements or public comments intended to be (or having the effect of being) of defamatory or disparaging nature regarding (including, without limitation, any statements or comments, whether in person, radio, television, film, social media or otherwise, that are (i) likely to be harmful to the business, business reputation or personal reputation of and (ii) for, on behalf of or in association with any trade, industry, activist or other advocacy group that has, at any time, made adverse or critical statements in relation to) the Company or any of its subsidiaries or affiliates or any of their respective businesses, shareholders, members, partners, employees, agents, officers, directors or contractors (it being understood that comments made in Executive’s good faith performance of his duties hereunder shall not be deemed disparaging or defamatory for purposes of this paragraph).  The Company (via any official statement) shall not, and shall instruct its officers and directors to not, at any time make any public statements or public release which is intended to be (or having the effect of being) of defamatory or disparaging nature regarding Executive’s reputation in the business community (it being understood that comments made by the Company in the good faith and ordinary course of business shall not be deemed disparaging or defamatory for purposes of this paragraph). Notwithstanding anything in this section 1(c), either the Executive or the Company 

-2-

 

		
(including its officers and directors) shall be permitted to (x) provide a reasonable and truthful response to or statement to defend itself or him/herself against any public statement made by the Company or the Executive, as applicable, that is incorrect or disparages such person, to the extent necessary to correct or refute such public statement and (y) provide truthful testimony in any legal proceeding or process. 

	
(d)
	
It is expressly understood and agreed that although Executive and the Company consider the restrictions contained in this Section 1 to be reasonable, if a final judicial determination is made by a court of competent jurisdiction that the time or territory or any other restriction contained in this Appendix B is an unenforceable restriction against Executive, the provisions of this Appendix B shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable. Alternatively, if any court of competent jurisdiction finds that any restriction contained in this Appendix B is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the enforceability of any of the other restrictions contained herein.

	
(e)
	
The period of time during which the provisions of this Section 1 shall be in effect shall be extended by the length of time during which Executive is in breach of the terms hereof as determined by any court of competent jurisdiction on the Company’s application for injunctive relief.

	
(f)
	
The provisions of Section 1 hereof shall survive the termination of Executive’s employment for any reason, including but not limited to, any termination other than for Cause (except as otherwise set forth in Section 1 hereof).

	
2.
	
Confidentiality; Intellectual Property.

	
(a)
	
Confidentiality.

	
(i)
	
Executive will not at any time (whether during or after Executive’s Employment Term) (x) retain or use for the benefit, purposes or account of Executive or any other Person; or (y) disclose, divulge, reveal, communicate, share, transfer or provide access to any Person outside the Company (other than its professional advisers who are bound by confidentiality obligations or otherwise in performance of Executive’s duties under Executive’s employment and pursuant to customary industry practice), any non-public, proprietary or confidential information —including without limitation trade secrets, know-how, research and development, software, databases, inventions, processes, formulae, technology, designs and other intellectual property, information concerning finances, investments, profits, pricing, costs, products, services, vendors, customers, clients, partners, investors, personnel, compensation, recruiting, training, advertising, sales, marketing, promotions, government and regulatory activities and approvals, safety, zoological and/or animal training or care practices, protocols, policies or procedures — concerning the past, current or future business, activities and operations of the Company, its subsidiaries or affiliates and/or any third party that has disclosed or provided any of same to the Company on a confidential basis (“Confidential Information”) without the prior written authorization of the Board.

-3-

 

	
(ii)
	
“Confidential Information” shall not include any information that is (a) generally known to the industry or the public other than as a result of Executive’s breach of this covenant; (b) made legitimately available to Executive by a third party without breach of any confidentiality obligation of which Executive has knowledge; or (c) required by law to be disclosed; provided that with respect to subsection (c) Executive shall give prompt written notice to the Company of such requirement, disclose no more information than is so required, and reasonably cooperate with any attempts by the Company to obtain a protective order or similar treatment.

	
(iii)
	
Except as required by law, Executive will not disclose to anyone, other than Executive’s family (it being understood that, in this Agreement, the term “family” refers to Executive, Executive’s spouse, children, parents and spouse’s parents) and advisors, the existence or contents of this Agreement; provided that Executive may disclose to any prospective future employer the provisions of this Appendix B. This Section 2(a)(iii) shall terminate if the Company publicly discloses a copy of this Agreement (or, if the Company publicly discloses summaries or excerpts of this Agreement, to the extent so disclosed).

	
(iv)
	
Upon termination of Executive’s employment with the Company for any reason, Executive shall (x) cease and not thereafter commence use of any Confidential Information or intellectual property (including without limitation, any patent, invention, copyright, trade secret, trademark, trade name, logo, domain name or other source indicator) owned or used by the Company, its subsidiaries or affiliates; and (y) immediately destroy, delete, or return to the Company, at the Company’s option, all originals and copies in any form or medium (including memoranda, books, papers, plans, computer files, letters and other data) in Executive’s possession or control (including any of the foregoing stored or located in Executive’s office, home, laptop or other computer, whether or not Company property) that contain Confidential Information, except that Executive may retain only those portions of any personal notes, notebooks and diaries that do not contain any Confidential Information. 

	
(v)
	
Nothing in this Agreement shall prohibit or impede Executive from communicating, cooperating, or filing a complaint with any U.S. federal, state, or local governmental or law enforcement branch, agency, or entity (collectively, a “Governmental Entity”) with respect to possible violations of any U.S. federal, state, or local law or regulation, or otherwise making disclosures to any Governmental Entity, in each case, that are protected under the whistleblower provisions of any such law or regulation, provided that in each case such communications and disclosures are consistent with applicable law.  Executive understands and acknowledges that an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that is made (i) in confidence to a Federal, State, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Executive understands and acknowledges further that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the 

-4-

 

		
individual files any document containing the trade secret under seal, and does not disclose the trade secret, except pursuant to court order.  Moreover, Executive is not required to give prior notice to (or get prior authorization from) the Company regarding any such communication or disclosure.  Notwithstanding the foregoing, under no circumstance will Executive be authorized to disclose any information covered by attorney-client privilege or attorney work product of any member of the Company Group without prior written consent of Company’s General Counsel or other officer designated by the Company. 

	
(b)
	
Intellectual Property.

	
(i)
	
If Executive has created, invented, designed, developed, contributed to or improved any works of authorship, inventions, intellectual property, materials, documents or other work product (including without limitation, research, reports, software, databases, systems, applications, presentations, textual works, content, or audiovisual materials) (“Works”), either alone or with third parties, prior to Executive’s employment by the Company, that are relevant to or implicated by such employment (“Prior Works”), Executive hereby grants the Company a perpetual, non-exclusive, royalty-free, worldwide, assignable, sublicensable license under all rights and intellectual property rights (including rights under patent, industrial property, copyright, trademark, trade secret, unfair competition and related laws) therein for all purposes in connection with the Company’s current and future business.

	
(ii)
	
If Executive creates, invents, designs, develops, contributes to or improves any Works, either alone or with third parties, at any time during Executive’s employment by the Company and within the scope of such employment and with the use of any the Company resources (“Company Works”), Executive shall promptly and fully disclose same to the Company and hereby irrevocably assigns, transfers and conveys, to the maximum extent permitted by applicable law, all rights and intellectual property rights therein (including rights under patent, industrial property, copyright, trademark, trade secret, unfair competition and related laws) to the Company to the extent ownership of any such rights does not vest originally in the Company.

	
(iii)
	
Executive shall take all reasonably requested actions and execute all reasonably requested documents (including any licenses or assignments required by a government contract) at the Company’s expense (but without further remuneration) to assist the Company in validating, maintaining, protecting, enforcing, perfecting, recording, patenting or registering any of the Company’s rights in the Prior Works and Company Works. If the Company is unable for any other reason, after reasonable attempt, to secure Executive’s signature on any document for this purpose, then Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Executive’s agent and attorney in fact, to act for and in Executive’s behalf and stead to execute any documents and to do all other lawfully permitted acts required in connection with the foregoing.

	
(iv)
	
Executive shall not improperly use for the benefit of, bring to any premises of, divulge, disclose, communicate, reveal, transfer or provide access to, or 

-5-

 

		
share with the Company any confidential, proprietary or non-public information or intellectual property relating to a former employer or other third party without the prior written permission of such third party. Executive shall comply with all relevant policies and guidelines of the Company that are from time to time previously disclosed to Executive, including regarding the protection of Confidential Information and intellectual property and potential conflicts of interest. Executive acknowledges that the Company may amend any such policies and guidelines from time to time, and that Executive remains at all times bound by their most current version from time to time previously disclosed to Executive.

	
(v)
	
The provisions of Section 2 hereof shall survive the termination of Executive’s employment for any reason (except as otherwise set forth in Section 2(a)(iii) hereof).

 

-6-

 

Exhibit A

RELEASE OF CLAIMS

As used in this Release of Claims (this “Release”), the term “claims” will include all claims, covenants, warranties, promises, undertakings, actions, suits, causes of action, obligations, debts, accounts, attorneys’ fees, judgments, losses, and liabilities, of whatsoever kind or nature, in law, in equity, or otherwise.

For and in consideration of the Severance Benefits (as defined in my Employment Agreement, dated November 6, 2019, with SeaWorld Entertainment, Inc. (the “Employment Agreement”)), and other good and valuable consideration, I, Sergio Rivera, for and on behalf of myself and my heirs, administrators, executors, and assigns, effective the date on which this release becomes effective pursuant to its terms, do fully and forever release, remise, and discharge each of the Company and each of its direct and indirect subsidiaries and affiliates, together with their respective officers, directors, partners, shareholders, employees, and agents (collectively, the “Group”) from any and all claims whatsoever up to the date hereof that I had, may have had, or now have against the Group, for or by reason of any matter, cause, or thing whatsoever, including any claim arising out of or attributable to my employment or the termination of my employment with the Company, whether for tort, breach of express or implied employment contract, intentional infliction of emotional distress, wrongful termination, unjust dismissal, defamation, libel, or slander, or under any federal, state, or local law dealing with discrimination based on age, race, sex, national origin, handicap, religion, disability, or sexual orientation. This release of claims includes, but is not limited to, all claims arising under the Age Discrimination in Employment Act (“ADEA”), Title VII of the Civil Rights Act, the Americans with Disabilities Act, the Civil Rights Act of 1991, the Family Medical Leave Act, and the Equal Pay Act, each as may be amended from time to time, and all other federal, state, and local laws, the common law, and any other purported restriction on an employer’s right to terminate the employment of employees. The release contained herein is intended to be a general release of any and all claims to the fullest extent permissible by law.

I acknowledge and agree that as of the date I execute this Release, I have no knowledge of any facts or circumstances that give rise or could give rise to any claims under any of the laws listed in the preceding paragraph.

By executing this Release, I specifically release all claims relating to my employment and its termination under ADEA, a United States federal statute that, among other things, prohibits discrimination on the basis of age in employment and employee benefit plans.

Notwithstanding any provision of this Release to the contrary, by executing this Release, I am not releasing (i) any claims relating to my rights under Section 6 of the Employment Agreement, (ii) any claims that cannot be waived by law, (iii) my right of indemnification as provided by, and in accordance with the terms of, the Company’s by-laws or a Company insurance policy providing such coverage, as any of such may be amended from time to time; (iv) my accrued and vested benefits, rights or payments under any employee benefit, incentive or equity plan or program of the Company; or (v) my rights under Section 14 of the Employment Agreement.

 

 

I expressly acknowledge and agree that I –

	
 
	
•
	
Am able to read the language, and understand the meaning and effect, of this Release;

	
 
	
•
	
Have no physical or mental impairment of any kind that has interfered with my ability to read and understand the meaning of this Release or its terms, and that I am not acting under the influence of any medication, drug, or chemical of any type in entering into this Release;

	
 
	
•
	
Am specifically agreeing to the terms of the release contained in this Release because the Company has agreed to pay me the Severance Benefits in consideration for my agreement to accept it in full settlement of all possible claims I might have or ever had, and because of my execution of this Release;

	
 
	
•
	
Acknowledge that, but for my execution of this Release, I would not be entitled to the Severance Benefits;

	
 
	
•
	
Understand that, by entering into this Release, I do not waive rights or claims under ADEA that may arise after the date I execute this Release;

	
 
	
•
	
Had or could have [twenty-one (21)][forty-five (45)]1 days from the date of my termination of employment (the “Release Expiration Date”) in which to review and consider this Release, and that if I execute this Release prior to the Release Expiration Date, I have voluntarily and knowingly waived the remainder of the review period;

	
 
	
•
	
Have not relied upon any representation or statement not set forth in this Release or my Employment Agreement made by the Company or any of its representatives;

	
 
	
•
	
Was advised to consult with my attorney regarding the terms and effect of this Release; and

	
 
	
•
	
Have signed this Release knowingly and voluntarily.

I represent and warrant that I have not previously filed, and to the maximum extent permitted by law agree that I will not file, a complaint, charge, or lawsuit against any member of the Group regarding any of the claims released herein. If, notwithstanding this representation and warranty, I have filed or file such a complaint, charge, or lawsuit, I agree that I shall cause such complaint, charge, or lawsuit to be dismissed with prejudice and shall pay any and all costs required in obtaining dismissal of such complaint, charge, or lawsuit, including without 

	
	 

	
1
	
 To be selected based on whether applicable termination was “in connection with an exit incentive or other employment termination program” (as such phrase is defined in the Age Discrimination in Employment Act of 1967).

-2-

 

 

limitation the attorneys’ fees of any member of the Group against whom I have filed such a complaint, charge, or lawsuit. This paragraph shall not apply, however, to a claim of age discrimination under ADEA or to any non-waivable right to file a charge with the United States Equal Employment Opportunity Commission (the “EEOC”); provided, however, that if the EEOC were to pursue any claims relating to my employment with Company, I agree that I shall not be entitled to recover any monetary damages or any other remedies or benefits as a result and that this Release and the Severance Benefits will control as the exclusive remedy and full settlement of all such claims by me.

I hereby agree to waive any and all claims to re-employment with the Company or any other member of the Company Group (as defined in my Employment Agreement) affirmatively agree not to seek further employment with the Company or any other member of the Company Group.

Notwithstanding anything contained herein to the contrary, this Release will not become effective or enforceable prior to the expiration of the period of seven (7) calendar days following the date of its execution by me (the “Revocation Period”), during which time I may revoke my acceptance of this Release by notifying the Company and the Board of Directors of the Company, in writing, delivered to the Company at its principal executive office, marked for the attention of its Chief Legal Officer & General Counsel. To be effective, such revocation must be received by the Company no later than 11:59 p.m. on the seventh (7th) calendar day following the execution of this Release. Provided that the Release is executed and I do not revoke it during the Revocation Period, the eighth (8th) day following the date on which this Release is executed shall be its effective date. I acknowledge and agree that if I revoke this Release during the Revocation Period, this Release will be null and void and of no effect, and neither the Company nor any other member of the Company will have any obligations to pay me the Severance Benefits.

The provisions of this Release shall be binding upon my heirs, executors, administrators, legal personal representatives, and assigns. If any provision of this Release shall be held by any court of competent jurisdiction to be illegal, void, or unenforceable, such provision shall be of no force or effect. The illegality or unenforceability of such provision, however, shall have no effect upon and shall not impair the enforceability of any other provision of this Release.

EXCEPT WHERE PREEMPTED BY FEDERAL LAW, THIS RELEASE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH FEDERAL LAW AND THE LAWS OF THE STATE OF FLORIDA, APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN THAT STATE WITHOUT GIVING EFFECT TO THE PRINCIPLES OF CONFLICTS OF LAWS. I HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS RELEASE.

Capitalized terms used, but not defined herein, shall have the meanings ascribed to such terms in my Employment Agreement.

__________________________________

Sergio Rivera

-3-

 

 

Date:

-4-

 

 

Exhibit B

[Form of Sign-On PSU Award Agreement]

 

-5-EX-4.2

 Exhibit 4.2 

EXECUTION VERSION 

DH EUROPE FINANCE II S.À R.L., 

as Issuer 
 DANAHER
CORPORATION, 
 as Guarantor 

AND 
 THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., 
 as Trustee 
  

 
 SECOND
SUPPLEMENTAL INDENTURE 
 2.050% Senior Notes Due 2022 

2.200% Senior Notes Due 2024 

2.600% Senior Notes Due 2029 

3.250% Senior Notes Due 2039 

3.400% Senior Notes Due 2049 

Dated as of November 7, 2019 
  

 
  

 THIS SECOND SUPPLEMENTAL INDENTURE (this “Supplemental
Indenture”), dated as November 7, 2019, is among DH EUROPE FINANCE II S.À R.L., a private limited liability company, société à responsabilité limitée, duly organized and existing under
the laws of Luxembourg (the “Company”), having its registered office at 1B Heienhaff, L-1736 Senningerberg, Grand Duchy of Luxembourg and registered with the Luxembourg Trade and Companies
Register under number B 235.237, DANAHER CORPORATION, a corporation duly organized and existing under the laws of the State of Delaware (the “Guarantor”) and the indirect parent company of the Company, having its principal office at
2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, D.C. 20037-1701, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association duly organized and existing under the laws of the United States of America, as Trustee (the
“Trustee”). 
 RECITALS 

WHEREAS, the Company and the Guarantor have heretofore executed and delivered to the Trustee an Indenture dated as of
September 18, 2019, among the Company, the Guarantor and the Trustee (the “Base Indenture,” and together with this Supplemental Indenture, the “Indenture”), providing for the issuance from time to time of
series of the Company’s Securities and Guarantees of such Securities by the Guarantor; 
 WHEREAS, Section 901(g)
of the Base Indenture provides for the Company, the Guarantor and the Trustee to enter into an indenture supplemental to the Base Indenture to establish the form or terms of Securities of any series as permitted by Section 201 and
Section 301 of the Base Indenture; 
 WHEREAS, pursuant to Section 301 of the Base Indenture, the Company wishes
to provide for the issuance of five (5) new series of Securities to be known as its: (a) 2.050% Senior Notes due 2022 (the “2022 Notes”), (b) 2.200% Senior Notes due 2024 (the “2024 Notes”), (c) 2.600% Senior
Notes due 2029 (the “2029 Notes”), (d) 3.250% Senior Notes due 2039 (the “2039 Notes”) and (e) 3.400% Senior Notes due 2049 (the “2049 Notes,” and collectively with the 2022 Notes, the 2024 Notes,
the 2029 Notes and the 2039 Notes, the “Notes”). The forms of the Notes of each such series and the terms, provisions and conditions thereof shall be as set forth in this Supplemental Indenture; 

WHEREAS, the Guarantor desires to Guarantee each series of Notes on the terms set forth in Article 14 of the Base Indenture;
and 
 WHEREAS, the Company and the Guarantor have requested that the Trustee execute and deliver this Supplemental
Indenture, and all requirements necessary to make this Supplemental Indenture a valid and binding instrument enforceable in accordance with its terms, to make each series of Notes, when executed and delivered by the Company and authenticated by the
Trustee, the valid, binding and enforceable obligations of the Company, and to make the Guarantees of each series of Notes, when such series of Notes have been executed and delivered by the Company and authenticated by the Trustee, and when the
notations of Guarantee to be attached to each Note are executed and delivered by the Guarantor, the valid, binding and enforceable obligations of the Guarantor, in each case, have been done and performed, and the execution and delivery of this
Supplemental Indenture has been duly authorized in all respects; 

  
 - 2 - 

 NOW, THEREFORE, in consideration of the covenants and agreements set forth
herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 

ARTICLE I 
 DEFINITIONS 

Section 1.01 Relation to Base Indenture. This Supplemental Indenture constitutes an integral part of the Base
Indenture. 
 Section 1.02 Definition of Terms. For all purposes of this Supplemental Indenture: 

(a) capitalized terms used herein without definition shall have the meanings set forth in the Base Indenture; 

(b) a term defined anywhere in this Supplemental Indenture has the same meaning throughout and, to the extent any such
term conflicts with a corresponding term defined in the Base Indenture or is otherwise set forth both in this Supplemental Indenture and in the Base Indenture, such term as defined in this Supplemental Indenture shall supersede the corresponding
term defined in the Base Indenture with respect to the Notes; 
 (c) the singular includes the plural and vice versa;

 (d) headings are for convenience of reference only and do not affect interpretation; and 

(e) the following terms have the meanings given to them in this Section 1.02(e): 

“2022 Notes Interest Payment Date” shall have the meaning set forth in Section 2.05(b). 

“2024 Notes Interest Payment Date” shall have the meaning set forth in Section 2.05(b). 

“2029 Notes Interest Payment Date” shall have the meaning set forth in Section 2.05(b). 

“2039 Notes Interest Payment Date” shall have the meaning set forth in Section 2.05(b). 

“2049 Notes Interest Payment Date” shall have the meaning set forth in Section 2.05(b). 

“2022 Notes Maturity Date” shall have the meaning set forth in Section 2.02(a). 

“2024 Notes Maturity Date” shall have the meaning set forth in Section 2.02(b). 

  
 - 3 - 

 “2029 Notes Maturity Date” shall have the meaning set forth in
Section 2.02(c). 
 “2039 Notes Maturity Date” shall have the meaning set forth in Section 2.02(d). 

“2049 Notes Maturity Date” shall have the meaning set forth in Section 2.02(e). 

“Business Day” means any day other than a Saturday or Sunday, which is not a day on which banking institutions
in The City of New York are authorized or required by law, regulation or executive order to close. 
 “Change of
Control” means the occurrence of any of the following: (1) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any “person” (as that term is defined in
Section 13(d)(3) of the Exchange Act) (other than (a) the Guarantor or one of its Subsidiaries, (b) any employee benefit plan of such Person or its Subsidiaries, and any Person acting in its capacity as trustee, agent or other
fiduciary or administrator of any such plan and (c) Steven M. Rales and Mitchell P. Rales) becomes the “beneficial owner” (as defined in Rules 13d-3 and
13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the Guarantor’s Voting Stock or other Voting Stock into which the Guarantor’s Voting Stock is reclassified, consolidated,
exchanged or changed, measured by voting power rather than number of shares; (2) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more series of related
transactions, of all or substantially all of the Guarantor’s assets and the assets of the Guarantor’s Subsidiaries, taken as a whole, to any “person” (as that term is defined in Section 13(d)(3) of the Exchange Act) (other
than the Guarantor or one of its Subsidiaries); or (3) the Guarantor ceases to own, directly or indirectly, 100% of the equity interests of the Company, other than as a result of the merger or consolidation of the Company with and into the
Guarantor. Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1) the Guarantor becomes a direct or indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders
of the Voting Stock of such holding company immediately following that transaction are substantially the same as the holders of the Guarantor’s Voting Stock immediately prior to that transaction or (B) immediately following that
transaction no Person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company. 

“Change of Control Offer” shall have the meaning set forth in Section 3.03. 

“Change of Control Payment” shall have the meaning set forth in Section 3.03. 

“Change of Control Payment Date” shall have the meaning set forth in Section 3.03. 

“Change of Control Triggering Event,” with respect to any series of Notes, means the occurrence of both a
Change of Control and a Rating Event with respect to such series. No Change of Control Triggering Event will be deemed to have occurred in connection with any particular Change of Control unless and until such Change of Control has actually been
consummated. 

  
 - 4 - 

 “Comparable Treasury Issue” means the United States
Treasury security selected by the Quotation Agent as having an actual interpolated maturity comparable to the remaining term of the Notes of a series to be redeemed (assuming that, with respect to the 2024 Notes, the 2029 Notes, the 2039 Notes and
the 2049 Notes, such notes to be redeemed matured on the applicable Par Call Date) that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable
maturity to the remaining term of the Notes of such series. 
 “Comparable Treasury Price” means, with
respect to any Redemption Date, (i) the average of four Reference Treasury Dealer Quotations for such Redemption Date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Company obtains fewer
than four such Reference Treasury Dealer Quotations, the average of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such Reference Treasury Dealer Quotation. 

“Depositary” means The Depository Trust Company or such successor selected or approved by the Company. 

“Envista” means Envista Holdings Corporation, a Delaware corporation. 

“Envista Entities” means Envista Holdings Corporation, a Delaware corporation, and each of its Subsidiaries.

 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“GE Biopharma Acquisition” means the acquisition of the Biopharma Business of GE Life Sciences, by the
Guarantor pursuant to the Purchase Agreement. 
 “Global Note” shall have the meaning set forth in
Section 2.04. 
 “Interest Payment Date” means any 2022 Notes Interest Payment Date, 2024 Notes
Interest Payment Date, 2029 Notes Interest Payment Date, 2039 Notes Interest Payment Date or 2049 Notes Interest Payment Date, as applicable. 

“Investment Grade Rating” means a rating equal to or higher than Baa3 (or the equivalent) by Moody’s and BBB- (or the equivalent) by S&P; and, the equivalent investment grade credit rating from any additional rating agency or rating agencies selected by the Guarantor. 

“Issue Date” means November 7, 2019. 

“Maturity Date” means the 2022 Notes Maturity Date, the 2024 Notes Maturity Date, the 2029 Notes Maturity
Date, the 2039 Notes Maturity Date or the 2049 Notes Maturity Date, as applicable. 
 “Moody’s” means
Moody’s Investors Service Inc., and any successor to its rating agency business. 

  
 - 5 - 

 “Par Call Date” means in the case of the 2024 Notes,
October 15, 2024; in the case of the 2029 Notes, August 15, 2029; in the case of the 2039 Notes, May 15, 2039; and in the case of the 2049 Notes, May 15, 2049. 

“Quotation Agent” means the Reference Treasury Dealer appointed by the Company. 

“Purchase Agreement” means the equity and asset purchase agreement, dated February 25, 2019, by and
between General Electric Company and the Guarantor as in effect on September 18, 2019. 
 “Rating
Agency” means (1) each of Moody’s and S&P; and (2) if either of Moody’s or S&P ceases to rate the applicable series of Notes or fails to make a rating of such series of Notes publicly available for reasons
outside of the Company’s or the Guarantor’s control, a “nationally recognized statistical rating organization” within the meaning of Section 3(a)(62) of the Exchange Act selected by the Guarantor (as certified by a Board
Resolution of the Guarantor) as a replacement agency for Moody’s or S&P, or both of them, as the case may be. 

“Rating Event” means the rating on the applicable series of Notes is lowered by each of the Rating Agencies
and such series of Notes is rated below an Investment Grade Rating by each of the Rating Agencies on any day within the 60-day period (which 60-day period will be
extended so long as the rating of such series of Notes is under publicly announced consideration for a possible downgrade by any of the Rating Agencies) after the earlier of (1) the occurrence of a Change of Control and (2) public notice
of the occurrence of a Change of Control or the Guarantor’s intention to effect a Change of Control; provided, however, that a Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have
occurred in respect of a particular Change of Control (and thus will not be deemed a Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition
would otherwise apply do not announce or publicly confirm or inform the Trustee in writing at the Company’s or its request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result
of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Rating Event). 

“Record Date” means May 1 or November 1, whether or not a Business Day, immediately preceding the
related Interest Payment Date, which constitutes a Regular Record Date for purposes of the Base Indenture. 

“Redemption Date” means, with respect to any redemption of any series of Notes, the date fixed for such
redemption pursuant to the Indenture and such series of Notes. 
 “Reference Treasury Dealer” means
(i) BofA Securities, Inc. and Wells Fargo Securities, LLC (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided, however, that if any of the foregoing shall cease to be a primary U.S.
Government securities dealer in the United States of America (a “Primary Treasury Dealer”), the Company will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary Treasury Dealer selected by the
Company. 

  
 - 6 - 

 “Reference Treasury Dealer Quotations” means, with respect
to each Reference Treasury Dealer and any Redemption Date, the average, as determined by the Company, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to
the Company by such Reference Treasury Dealer at 3:30 p.m., New York City time, on the third Business Day preceding such Redemption Date. 

“Remaining Scheduled Payments” means, with respect to each series of Notes to be redeemed, the remaining
scheduled payments of the principal thereof and interest thereon that would be due after the related Redemption Date (assuming that, with respect to the 2024 Notes, the 2029 Notes, the 2039 Notes and the 2049 Notes, such Notes to be redeemed matured
on the applicable Par Call Date) but for such redemption; provided, however, that, if such Redemption Date is not an Interest Payment Date with respect to the Notes of such series, the amount of the next succeeding scheduled interest payment thereon
will be deemed to be reduced by the amount of interest accrued thereon to such Redemption Date. 
 “S&P”
means S&P Global Ratings, a division of S&P Global Inc., and any successor to its rating agency business. 

“Separation Transaction” means any transaction in furtherance of the Guarantor’s previously disclosed
intentions to dispose of the common stock of Envista, including, without limitation, (i) an initial public offering or other offering(s) of shares of Envista, (ii) the distribution to the Guarantor of all or a portion of the proceeds of
such offering(s) and/or the proceeds of borrowings under the Envista Entities’ senior term credit facilities and (iii) the distribution by the Guarantor to its shareholders of all or a portion of the remaining equity interests in Envista
owned by the Guarantor, by means of a spin-off of Envista shares effected as a dividend to all the Guarantor’s shareholders, a split-off of Envista shares in
exchange for shares of the Guarantor or other securities, or any combination of the foregoing in one transaction or in a series of transactions. 

“Special Mandatory Redemption Date” means the earlier to occur of (1) September 24, 2020, if the GE
Biopharma Acquisition has not been completed on or prior to August 25, 2020 (or such later date to which the Purchase Agreement may be extended in accordance with its terms), or (2) the 30th day (or if such day is not a Business Day, the
first Business Day thereafter) following the termination of the Purchase Agreement. 
 “Special Mandatory Redemption
Price” shall have the meaning set forth in Section 3.04(a). 
 “Subsidiary” of any specified
Person means any corporation or other entity (including, without limitation, partnerships, joint ventures and associations) of which at least a majority of the outstanding stock having by the terms thereof ordinary voting power for the election of
directors of such corporation or other entity (irrespective of whether or not at the time stock of any other class or classes of such corporation shall have or might have voting power by reason of the happening of any contingency) is at the time
directly or indirectly owned by such Person, or by one or more Subsidiaries, or by such Person and one or more other Subsidiaries; provided, that, the Envista Entities shall be excluded from any such reference to a Subsidiary other than for
purposes of the “Envista Entities” definition. 

  
 - 7 - 

 “Treasury Rate” means, with respect to any Redemption Date,
the rate per annum equal to the semi-annual equivalent yield to maturity (or interpolated yield to maturity on a day count basis) of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its
principal amount) equal to the Comparable Treasury Price of such Redemption Date. 
 “Voting Stock” means,
with respect to any specified Person as of any date, the capital stock of such Person that is at the time entitled to vote generally in the election of the Board of Directors or similar governing body of such Person. 

The terms “Base Indenture,” “Company,” “Guarantor,”
“Indenture,” “Notes” and “Trustee” shall have the respective meanings set forth in the recitals to this Supplemental Indenture and the paragraph preceding such recitals. 

ARTICLE II 
 GENERAL TERMS AND
CONDITIONS OF THE NOTES 
 Section 2.01 Designation and Principal Amount. Each series of Notes may be
issued from time to time upon written order of the Company for the authentication and delivery of such series of Notes pursuant to Section 303 of the Base Indenture. There are hereby authorized: 

(a) a series of Securities designated as the 2.050% Senior Notes due 2022, limited in initial aggregate principal amount
to $700,000,000 (except upon registration of transfer of, or in exchange for, or in lieu of, other Securities pursuant to Section 304, 305, 306, 906 or 1107 of the Base Indenture); 

(b) a series of Securities designated as the 2.200% Senior Notes due 2024, limited in initial aggregate principal amount
to $700,000,000 (except upon registration of transfer of, or in exchange for, or in lieu of, other Securities pursuant to Section 304, 305, 306, 906 or 1107 of the Base Indenture); 

(c) a series of Securities designated as the 2.600% Senior Notes due 2029, limited in initial aggregate principal amount
to $800,000,000 (except upon registration of transfer of, or in exchange for, or in lieu of, other Securities pursuant to Section 304, 305, 306, 906 or 1107 of the Base Indenture); 

(d) a series of Securities designated as the 3.250% Senior Notes due 2039, limited in initial aggregate principal amount
to $900,000,000 (except upon registration of transfer of, or in exchange for, or in lieu of, other Securities pursuant to Section 304, 305, 306, 906 or 1107 of the Base Indenture); and 

(e) a series of Securities designated as the 3.400% Senior Notes due 2049, limited in initial aggregate principal amount
to $900,000,000 (except upon registration of transfer of, or in exchange for, or in lieu of, other Securities pursuant to Section 304, 305, 306, 906 or 1107 of the Base Indenture). 

  
 - 8 - 

 The Company may create and issue additional Notes of any series having the same terms and
conditions as such series of Notes in all respects (or in all respects except for the Issue Date, issue price and, to the extent applicable, the payment of interest accruing prior to the Issue Date of such additional Notes or the first payment of
interest following the Issue Date), so that such additional Notes of such series will be consolidated and form a single series with the initial Notes of such series. 

Section 2.02 Maturity. (a) The date upon which the 2022 Notes shall become due and payable
at final maturity, together with any accrued and unpaid interest, is November 15, 2022 (the “2022 Notes Maturity Date”), (b) the date upon which the 2024 Notes shall become due and payable at final maturity, together
with any accrued and unpaid interest, is November 15, 2024 (the “2024 Notes Maturity Date”), (c) the date upon which the 2029 Notes shall become due and payable at final maturity, together with any accrued and
unpaid interest, is November 15, 2029 (the “2029 Notes Maturity Date”), (d) the date upon which the 2039 Notes shall become due and payable at final maturity, together with any accrued and unpaid interest, is
November 15, 2039 (the “2039 Notes Maturity Date”) and (e) the date upon which the 2049 Notes shall become due and payable at final maturity, together with any accrued and unpaid interest, is
November 15, 2049 (the “2049 Notes Maturity Date”). 
 Section 2.03 Form, Payment
and Appointment. Except as provided in Section 2.04, each series of Notes shall be issued in fully registered, certificated form. Principal of and interest on each series of Notes will be payable, the transfer of such series of Notes will
be registrable, and such series of Notes will be exchangeable for such series of Notes of a like aggregate principal amount, at the office or agency of the Company maintained for such purpose located at 240 Greenwich Street, New York, New York
10286, which shall initially be the corporate trust office of the Trustee; provided, however, that payment of interest may be made at the option of the Company by check mailed to the Person entitled thereto at such address as shall
appear in the Security register or by wire transfer to an account appropriately designated by the Person entitled to payment; provided, that the Paying Agent shall have received written notice of such account designation at least five
(5) Business Days prior to the date of such payment (subject to surrender of the relevant Note in the case of a payment of interest on a Redemption Date or the Maturity Date). 

No service charge shall be made for any registration of transfer or exchange of any series of Notes, but the Company may
require payment from the applicable Holder of a sum sufficient to cover any tax or other governmental charge that may be imposed in connection therewith. 

The Security Registrar and Paying Agent for the Notes shall initially be the Trustee. 

The Notes of each series shall be issuable in denominations of U.S. $2,000 and integral multiples of U.S. $1,000 in excess
thereof. 
 The specified currency of the Notes shall be U.S. Dollars. 

Section 2.04 Global Notes. The Notes of each series shall be issued initially in the form of a permanent
Global Security in registered form (each, a “Global Note”), deposited with the Depositary. Unless and until such Global Note is exchanged for Notes of such series in certificated form, such Global Note may be transferred, in whole
but not in part, and any payments on the Notes of such series shall be made to the Paying Agent, which in turn shall make payment with respect to the applicable series of Notes to the Depositary or a nominee of the Depositary. 

  
 - 9 - 

 Section 2.05 Interest on the Notes.
(a) Interest payable on any Interest Payment Date, Maturity Date or Redemption Date, shall be the amount of interest accrued from, and including, the immediately preceding Interest Payment Date in respect of which interest has
been paid or duly provided for (or from and including the Issue Date, if no interest has previously been paid or duly provided for) to, but excluding, such Interest Payment Date, Maturity Date or, if applicable, Redemption Date, as the case may be.
Interest on the Notes will be computed on the basis of a 360-day year consisting of twelve 30-day months. 

(b) The 2022 Notes will bear interest at the rate of 2.050% per year; the 2024 Notes will bear interest at the rate of
2.200% per year; the 2029 Notes will bear interest at the rate of 2.600% per year; the 2039 Notes will bear interest at the rate of 3.250% per year; and the 2049 Notes will bear interest at the rate of 3.400% per year. Interest on the 2022 Notes
shall be payable semi-annually in arrears on May 15 and November 15 of each year (each, a “2022 Notes Interest Payment Date”), commencing May 15, 2020; interest on the 2024 Notes shall be payable
semi-annually in arrears on May 15 and November 15 of each year (each, a “2024 Notes Interest Payment Date”), commencing May 15, 2020; interest on the 2029 Notes shall be payable semi-annually in arrears
on May 15 and November 15 of each year (each, a “2029 Notes Interest Payment Date”), commencing May 15, 2020; interest on the 2039 Notes shall be payable semi-annually in arrears on May 15 and
November 15 of each year (each, a “2039 Notes Interest Payment Date”), commencing May 15, 2020; and interest on the 2049 Notes shall be payable semi-annually in arrears on May 15 and November 15 of
each year (each, a “2049 Notes Interest Payment Date”), commencing May 15, 2020, in each case to the Persons in whose names such Notes are registered at the close of business on the Record Date for such Interest Payment
Date, except as provided in Section 2.06. 
 Section 2.06 In the event that any Interest Payment Date with
respect to any series of Notes or the Maturity Date or a Redemption Date for any series of Notes falls on a day that is not a Business Day, then the related payments of principal, premium, if any, and interest shall be made on the next succeeding
day that is a Business Day (and no additional interest will accrue or otherwise accumulate on the amount payable for the period from and after such Interest Payment Date, Maturity Date or Redemption Date, as applicable). Interest due on the Maturity
Date or a Redemption Date (in each case, whether or not an Interest Payment Date) of any series of Notes will be paid to the Person to whom principal of such Notes is payable. 

Section 2.07 Payments of Additional Amounts. The provisions of Section 1502 of the Base Indenture shall
apply to each series of Notes. Whenever in any series of Notes there is mentioned, in any context, the payment of the principal of or interest or any other amounts on, or in respect of, such series of Notes, such mention shall be deemed to include
mention of the payment of Additional Amounts to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to the terms hereof and the Indenture, and express mention of the payment of Additional
Amounts in any provision of any series of Notes shall not be construed as excluding the payment of Additional Amounts in those provisions thereof where such express mention is not made. 

Section 2.08 No Sinking Fund. The Notes are not entitled to the benefit of any sinking fund. 

  
 - 10 - 

 Section 2.09 Guarantees. Each series of Notes shall have
the benefit of a Guarantee from the Guarantor on the terms set forth in Article 14 of the Base Indenture. 
 ARTICLE III 

REDEMPTION OF THE NOTES 

Section 3.01 Optional Redemption by Company. (a) At any time and from time to time prior
to (i) the applicable Par Call Date for the 2024 Notes, the 2029 Notes, the 2039 Notes and the 2049 Notes and (ii) the 2022 Notes Maturity Date for the 2022 Notes, the Company has the right, at its option, to redeem any series of Notes, in
whole or in part, at a redemption price equal to the greater of: 
 (i) 100% of the principal amount of the Notes to
be redeemed, and 
 (ii) the sum of the present values of the Remaining Scheduled Payments on such Notes to be
redeemed (not including any portion of the payments of interest that will be accrued and unpaid to and including the Redemption Date) discounted to the Redemption Date on a semi-annual basis (assuming a
360-day year consisting of twelve 30-day months) at the applicable Treasury Rate plus 10 basis points, in the case of the 2022 Notes, 10 basis points, in the case of the
2024 Notes, 15 basis points, in the case of the 2029 Notes, 15 basis points, in the case of the 2039 Notes and 20 basis points, in the case of the 2049 Notes, 

plus, in each case, accrued and unpaid interest, if any, on the principal amount of the Notes being redeemed to, but excluding, the Redemption
Date. 
 (b) On or after the applicable Par Call Date, the Company has the right, at its option, to redeem the 2024
Notes, the 2029 Notes, the 2039 Notes and the 2049 Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of such Notes to be redeemed, plus accrued and unpaid interest, if any, on
the principal amount of such Notes being redeemed to, but excluding, the Redemption Date. 
 (c) The Company will
cause the notice of any redemption to be mailed (or sent electronically in accordance with applicable Depositary procedures) to the registered Holders of the applicable Notes to be redeemed not less than 15 nor more than 60 days prior to the
Redemption Date. Any notice may, at the discretion of the Company be subject to the satisfaction or waiver of one or more conditions precedent. In that case, the notice shall state the nature of such condition precedent. If a series of Notes is only
partially redeemed pursuant to this Section 3.01, such Notes to be redeemed will be selected by the Trustee in such manner as in its sole discretion it shall deem appropriate and fair, subject to any applicable Depositary procedures. The price
for any redemption pursuant to this Section 3.01 shall be paid prior to 12:00 noon, New York City time, on the applicable Redemption Date or at such later time as is then permitted by the rules of the Depositary applicable to such series of
Notes (if then registered as Global Notes); provided, that the Company shall deposit with the Trustee or the Paying Agent an amount sufficient to pay the applicable redemption price by 10:00 a.m., New York City time, on the date such
redemption price is to be paid. 

  
 - 11 - 

 (d) If money sufficient to pay the redemption price of all of the
Notes (or a portion thereof) to be redeemed on the applicable Redemption Date is deposited with the Trustee or the Paying Agent on or before such Redemption Date as provided herein, then on and after such Redemption Date, interest will cease to
accrue on such series of Notes (or such portion thereof) called for redemption. 
 Section 3.02 Redemption Upon
Changes in Withholding Tax. The provisions of Section 1501 of the Base Indenture shall apply to each series of Notes. The redemption price for any redemption pursuant to this Section 3.02 shall be paid prior to 12:00 noon, New York
City time, on the applicable Redemption Date or at such later time as is then permitted by the rules of the Depositary applicable to the Notes (if then registered as Global Notes); provided, that the Company shall deposit with the Trustee or the
Paying Agent an amount sufficient to pay such redemption price by 10:00 a.m., New York City time, on the date such redemption price is to be paid. If money sufficient to pay such redemption price of each series of Notes to be redeemed on the
applicable Redemption Date is deposited with the Trustee or the Paying Agent on or before such Redemption Date as provided herein, then on and after such Redemption Date, interest will cease to accrue on such Notes called for redemption. 

Section 3.03 Change of Control Triggering Event. (a) If a Change of Control Triggering
Event occurs, unless the Company has exercised its right to redeem the Notes in full as described in Section 3.01, or with respect to any series of Notes, such series of Notes has become redeemable as described in Section 3.02 or 3.04,
Holders of each series of Notes will have the right to require the Company to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of their Notes pursuant to the offer described below (the “Change
of Control Offer”) on the terms set forth in the Notes. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid
interest, if any, on the Notes repurchased to the date of purchase (the “Change of Control Payment”). Within 30 days following any Change of Control Triggering Event, or, at the Company’s option, prior to the date of the
consummation of any Change of Control, but after public announcement of the transaction that constitutes or may constitute the Change of Control, the Company will be required to mail a notice to Holders of each applicable series of Notes, with a
copy to the Trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Triggering Event and offering to repurchase such applicable series of Notes on the date specified in the notice, which date will
be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the “Change of Control Payment Date”), pursuant to the procedures required by the Notes and described in such notice. The notice shall, if
mailed prior to the date of the consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date. The Company must comply
with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of
the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Triggering Event provisions of the Notes, the Company will comply with the
applicable securities laws and regulations and will not be deemed to have breached its obligations under this Section 3.03 or the Change of Control Triggering Event provisions of the Notes by virtue of such conflicts. 

  
 - 12 - 

 (b) On the Change of Control Payment Date, the Company will be
required, to the extent lawful, to: 
 (i) accept for payment all Notes of each applicable series, or portions of such
Notes, properly tendered pursuant to the Change of Control Offer; 
 (ii) deposit with the Paying Agent an amount
equal to the Change of Control Payment in respect of all Notes of each applicable series, or portions of such Notes, properly tendered; and 

(iii) deliver or cause to be delivered to the Trustee the Notes of each applicable series properly accepted together
with an Officers’ Certificate stating the aggregate principal amount of such Notes, or portions of such Notes, being repurchased. 

(c) The Paying Agent will promptly mail to each Holder of Notes of each applicable series properly tendered the Change
of Control Payment for such Notes, and the Trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each such Holder a new Note of such series equal in principal amount to any unpurchased portion of any Notes of such
series surrendered; provided that each new Note will be in a principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. The Company will not be required to make an offer to repurchase Notes of any series upon a Change of
Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all Notes of each such series properly
tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an Event of Default under the Indenture, other than a default in the
payment of the Change of Control Payment upon a Change of Control Triggering Event. 
 Section 3.04 Special
Mandatory Redemption. (a) In the event that the Guarantor does not consummate the GE Biopharma Acquisition on or prior to August 25, 2020 (or such later date to which the Purchase Agreement may be extended in accordance
with its terms), or the Purchase Agreement is terminated at any time prior to August 25, 2020, then the Company must redeem, in whole and not in part, each series of Notes on the Special Mandatory Redemption Date at a redemption price (the
“Special Mandatory Redemption Price”) equal to 101% of the aggregate principal amount of each such series of Notes outstanding, plus accrued and unpaid interest from the most recent Interest Payment Date to which interest has
been paid or duly provided for or, if no interest has been paid, from the Issue Date to, but excluding, the Special Mandatory Redemption Date. 

(b) The Company will cause the notice of such Special Mandatory Redemption to be mailed, with a copy to the Trustee,
within five Business Days after the occurrence of the event triggering such Special Mandatory Redemption to each Holder of Notes at its registered address. The Special Mandatory Redemption Price shall be paid prior to 12:00 noon, New York City time,
on the Special Mandatory Redemption Date or at such later time as is then permitted by the rules of the Depositary applicable to the Notes (if then registered as Global Notes); provided, that the Company shall deposit with the Trustee or the Paying
Agent an amount sufficient to pay the Special Mandatory Redemption Price by 10:00 a.m., New York City time, on the date such Special Mandatory Redemption Price is to be paid. 

  
 - 13 - 

 (c) If money sufficient to pay the Special Mandatory Redemption Price
of each series of Notes to be redeemed on the Special Mandatory Redemption Date is deposited with the Trustee or Paying Agent on or before the Special Mandatory Redemption Date as provided herein, then on and after such Special Mandatory Redemption
Date, interest will cease to accrue on such Notes. 
 ARTICLE IV 

FORM OF NOTES AND GUARANTEES 

Section 4.01 Form of Notes and Guarantees. The Notes and the Trustee’s Certificates of Authentication to
be endorsed thereon are to be substantially in the forms attached as Exhibits A through E hereto, in each case with such changes therein as the officers of the Company executing the Notes (by manual or facsimile signature) may approve,
such approval to be conclusively evidenced by his or her execution thereof. The notation of Guarantee to be attached to each Note is to be substantially in the form attached as Exhibit F hereto, with such changes therein as the officer of the
Guarantor executing the notation of Guarantee (by manual or facsimile signature) may approve, such approval to be conclusively evidenced by their execution thereof. 

ARTICLE V 
 ORIGINAL ISSUE OF NOTES

 Section 5.01 Original Issue of Notes. 2022 Notes having an initial aggregate principal amount of
$700,000,000, 2024 Notes having an initial aggregate principal amount of $700,000,000, 2029 Notes having an initial aggregate principal amount of $800,000,000, 2039 Notes having an initial aggregate principal amount of $900,000,000 and 2049 Notes
having an initial aggregate principal amount of $900,000,000 may from time to time, upon execution of this Supplemental Indenture, be executed by the Company and delivered to the Trustee for authentication, and the Trustee shall thereupon
authenticate and deliver said Notes to or upon the written order of the Company pursuant to Section 303 of the Base Indenture without any further action by the Company (other than as required by the Base Indenture).  

ARTICLE VI 
 COVENANTS 

Section 6.01 Additional Exception to Limitation on Secured Debt. Section 1010 of the Indenture shall not
apply to debt secured by any security interests on any property, assets or equity or other ownership interests created to secure Indebtedness incurred by the Guarantor or any of its Subsidiaries in connection with a Separation Transaction; provided
that this clause shall cease to apply to any such security interests to the extent (1) the applicable Separation Transaction has not been consummated within 180 days of the creation of such security interests or (2) such security interests
continue to encumber property, assets or equity or other ownership interests of the Guarantor or any of its Subsidiaries as of a date which is 30 days after the consummation of such Separation Transaction. 

  
 - 14 - 

 ARTICLE VII 

MISCELLANEOUS 

Section 7.01 Ratification and Applicability of Indenture. To the extent of any conflict between the
provisions of this Supplemental Indenture and the Base Indenture, the provisions of this Supplemental Indenture shall control. The provisions of Sections 1302 and 1303 of the Base Indenture shall apply to the Notes (including with respect to
Section 6.01 of this Supplemental Indenture). Except as otherwise provided in Section 1.02 and this Section 7.01, the Base Indenture is in all respects ratified and confirmed, and this Supplemental Indenture shall be deemed part of
the Base Indenture in the manner and to the extent herein and therein provided. 
 Section 7.02 Trustee Not
Responsible for Recitals. The recitals herein contained are made by the Company and the Guarantor and not by the Trustee, and the Trustee assumes no responsibility for the correctness thereof. The Trustee makes no representation as to the
validity or sufficiency of this Supplemental Indenture. 
 Section 7.03 New York Law to Govern. THIS
SUPPLEMENTAL INDENTURE AND EACH NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF NEW YORK, AND FOR ALL PURPOSES SHALL BE CONSTRUED IN ACCORDANCE WITH THE LAWS OF SAID STATE. FOR THE AVOIDANCE OF DOUBT, THE APPLICABILITY OF
ARTICLES 470-3 to 470-19 OF THE LUXEMBOURG LAW DATED AUGUST 10, 1915 ON COMMERCIAL COMPANIES, AS AMENDED, SHALL BE EXCLUDED. 

Section 7.04 Separability. In case any one or more of the provisions contained in this Supplemental Indenture
or in any series of the Notes shall for any reason be held to be invalid, illegal or unenforceable in any respect, then, to the extent permitted by law, such invalidity, illegality or unenforceability shall not affect any other provisions of this
Supplemental Indenture or of such series of the Notes, but this Supplemental Indenture and such series of the Notes shall be construed as if such invalid or illegal or unenforceable provision had never been contained herein or therein. 

Section 7.05 Counterparts. This Supplemental Indenture may be executed in any number of counterparts each of
which shall be an original, but such counterparts shall together constitute but one and the same instrument. 

  
 - 15 - 

 IN WITNESS WHEREOF the parties hereto have caused this Supplemental Indenture to be duly
executed, as of the day and year first written above. 
  

			
	DH EUROPE FINANCE II S.À R.L.

 
			
		
	By:	 	 

 
			
	Name:	 	 

 
			
	Title:	 	 

  

			
	DANAHER CORPORATION

 
			
		
	By:	 	 

 
			
	Name:	 	 

 
			
	Title:	 	 

  

			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee

 
			
		
	By:	 	 

 
			
	Name:	 	 

 
			
	Title:	 	 

 [Signature Page to Second Supplemental Indenture] 

 EXHIBIT A 

[IF THIS NOTE IS TO BE A GLOBAL SECURITY, INSERT:] 

UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO
THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS
MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE & CO., HAS AN INTEREST HEREIN. 
 THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED
TO AND IS REGISTERED IN THE NAME OF DTC OR A NOMINEE THEREOF. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN DTC OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND MAY NOT BE
TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC. 
 DH EUROPE FINANCE II
S.À R.L. 
 2.050% Senior Note due 2022 
  

					
	          No.
                                    	  		  	$
                                        

 CUSIP: 23291K AF2 

ISIN: US23291KAF21 

DH Europe Finance II S.à r.l., a private limited liability company (société à
responsabilité limitée) duly organized and existing under the laws of Luxembourg, having its registered office at 1 B Heienhaff, L-1736 Senningerberg, Grand Duchy of Luxembourg and registered
with the Luxembourg Trade and Companies Register under number B 235.237 (herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay
to ________________, or registered assigns, the principal sum set forth in the Schedule of Increases or Decreases in Note attached hereto on November 15, 2022, and to pay interest thereon from November 7, 2019 or from the immediately
preceding Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on May 15 and November 15 of each year, commencing May 15, 2020 at the rate of 2.050% per annum, until the principal hereof
is paid or made available for payment. Interest shall be computed on the basis of a 360-day year consisting of twelve 30-day months. The interest so payable, and
punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Note (or one or more Predecessor Notes) is registered on the Security Register at the close of business
on the Regular Record Date for such interest, which shall be May 1 or November 1, whether or not a Business Day, immediately preceding the related Interest Payment Date, except as provided in Section 2.06 of the Supplemental
Indenture. 

  
 A-1 

 Any such interest not so punctually paid or duly provided for will forthwith
cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Note (or one or more Predecessor Notes) is registered at the close of business on a Special Record Date for the payment of such
Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of this Note not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of
any securities exchange on which the Notes of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

Payment of the principal of (and premium, if any) and interest on this Note will be made at the office or agency of the Company
maintained for that purpose in accordance with the Indenture, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of
the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or by wire transfer to an account maintained by the Person entitled thereto as specified
in the Security Register. 
 This Note is fully and unconditionally guaranteed by Danaher Corporation, a corporation duly
organized and existing under the laws of the State of Delaware (the “Guarantor”), as provided in the Indenture. 

Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall
for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has
been executed by the Trustee referred to on the reverse hereof by manual signature, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its corporate seal. 

Dated:
                             

 

			
	DH EUROPE FINANCE II S.À R.L.

 
			
		
	By: 	 	 

 
			
	Name:	 	 

 
			
	Title: 	 	 

  
 A-2 

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Notes of the series designated therein described in the within-mentioned Indenture. 

Dated:
                                        
 
 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., 

as Trustee 

By:                      
                               

Authorized Signatory 

  
 A-3 

 REVERSE OF NOTE 

This Note is one of a duly authorized issue of Securities of the Company (herein called the “Notes”), issued
and to be issued in one or more series under a Base Indenture, dated as of September 18, 2019 (as heretofore supplemented, herein called the “Base Indenture”), among the Company, the Guarantor and The Bank of New York Mellon
Trust Company, N.A., as Trustee (herein called the “Trustee,” which term includes any successor trustee under the Indenture), as supplemented by the Second Supplemental Indenture, dated as of November 7, 2019 (herein called the
“Supplemental Indenture,” which term shall have the meaning assigned to it in such instrument, and together with the Base Indenture, herein called the “Indenture”) and reference is hereby made to the Indenture for a
statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Guarantor, the Trustee and the Holders of the Notes and of the terms upon which the Notes are, and are to be authenticated and delivered.
This Note is one of the series designated on the face hereof initially limited in aggregate principal amount to $700,000,000. The Notes are unsecured general obligations of the Company. 

 

	 	1.	 Optional Redemption 

At any time and from time to time prior to November 15, 2022, the Company shall have the right to redeem the Notes, in
whole or in part, at its option, at a redemption price equal to the greater of: 
 (i) 100% of the principal amount of
the Notes to be redeemed; and 
 (ii) the sum of the present values of the Remaining Scheduled Payments on the Notes
to be redeemed (not including any portion of the payments of interest that will be accrued and unpaid to and including the Redemption Date) discounted to the Redemption Date on a semi-annual basis (assuming a
360-day year consisting of twelve 30-day months) at the applicable Treasury Rate plus 10 basis points, plus accrued and unpaid interest, if any, on the principal amount
of the Notes being redeemed to, but excluding, the Redemption Date. 
 The Company will mail (or send electronically in
accordance with applicable Depositary procedures) notice of any redemption to the registered Holders of the Notes to be redeemed not less than 15 nor more than 60 days prior to the Redemption Date. Any notice may, at the discretion of the Company be
subject to the satisfaction or waiver of one or more conditions precedent. In that case, the notice shall state the nature of such condition precedent. If the Notes are only partially redeemed pursuant to Section 3.01 of the Supplemental
Indenture, the Notes to be redeemed will be selected by the Trustee in such manner as in its sole discretion it shall deem appropriate and fair, subject to any applicable Depositary procedures. 

If money sufficient to pay the redemption price of all of the Notes (or a portion thereof) to be redeemed on the Redemption
Date is deposited with the Trustee or Paying Agent on or before the Redemption Date as provided herein and in the Indenture, then on and after such Redemption Date, interest will cease to accrue on such Notes (or such portion thereof) called for
redemption. 

  
 A-4 

 In the event of redemption of this Note in part only, a new Note or Notes
for the unredeemed portion hereof shall be issued in the name of the Holder hereof upon the cancellation hereof. 
  

	 	2.	 Special Mandatory Redemption 

In the event that the Guarantor does not consummate the GE Biopharma Acquisition on or prior to August 25, 2020 (or such
later date to which the Purchase Agreement may be extended in accordance with its terms) or the Purchase Agreement is terminated at any time prior thereto (or such later date to which the Purchase Agreement may be extended in accordance with
its terms), then the Company must redeem, in whole and not in part, all of the Notes on the Special Mandatory Redemption Date at a redemption price (the “Special Mandatory Redemption Price”) equal to 101% of the aggregate principal
amount of the Notes outstanding, plus accrued and unpaid interest from the most recent Interest Payment Date to which interest has been paid or duly provided for or, if no interest has been paid, from the Issue Date to, but excluding, the Special
Mandatory Redemption Date. 
 The Company will mail notice of such Special Mandatory Redemption, with a copy to the Trustee,
within five Business Days after the occurrence of the event triggering such Special Mandatory Redemption to each Holder of Notes at its registered address. 

If money sufficient to pay the Special Mandatory Redemption Price of all of the Notes to be redeemed on the Special Mandatory
Redemption Date is deposited with the Trustee or Paying Agent on or before the Special Mandatory Redemption Date as provided herein and in the Indenture, then on and after such Special Mandatory Redemption Date, interest will cease to accrue on such
Notes. 
  

	 	3.	 Redemption Upon Changes in Withholding Taxes; Additional Amounts 

The provisions of Sections 1501 and 1502 of the Base Indenture and Sections 2.07 and 3.02 of the Supplemental Indenture shall
apply to this series of Notes. 
 Whenever the payment of the principal of or interest or any other amounts on, or in respect
of, this Note is mentioned, in any context, such mention shall be deemed to include mention of the payment of Additional Amounts to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to the
terms of the Indenture, and express mention of the payment of Additional Amounts in any provision of this series of Notes shall not be construed as excluding the payment of Additional Amounts in those provisions thereof where such express mention is
not made. 
  

	 	4.	 No Other Redemption 

Except as set forth in Sections 1, 2 and 3 of this Note and in Article 3 of the Supplemental Indenture, the Company may not
redeem the Notes prior to the Maturity Date. 

  
 A-5 

	 	5.	 Change of Control Triggering Event 

If a Change of Control Triggering Event occurs, unless the Notes of this series have become redeemable as described in Sections
3.01 and 3.02 of the Supplemental Indenture, Holders of the Notes of this series will have the right to require the Company to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of their Notes pursuant
to the offer described below (the “Change of Control Offer”) on the terms set forth herein. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of
Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased to the date of purchase (the “Change of Control Payment”). Within 30 days following any Change of Control Triggering Event, or, at the
Company’s option, prior to the date of the consummation of any Change of Control, but after public announcement of the transaction that constitutes or may constitute the Change of Control, the Company will be required to mail a notice to
Holders of the Notes, with a copy to the Trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which
date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the “Change of Control Payment Date”), pursuant to the procedures required by the Indenture and described in such notice. The notice
shall, if mailed prior to the date of the consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date. 

On the Change of Control Payment Date, the Company will be required, to the extent lawful, to: 

(i) accept for payment all of the Notes, or portions of the Notes, properly tendered pursuant to the Change of Control
Offer; 
 (ii) deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all of the
Notes, or portions of the Notes, properly tendered; and 
 (iii) deliver or cause to be delivered to the Trustee the
Notes properly accepted together with an Officers’ Certificate stating the aggregate principal amount of Notes, or portions of Notes, being repurchased. 

The Paying Agent will promptly mail to each Holder of Notes properly tendered the Change of Control Payment for such Notes, and
the Trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each such Holder a new Note equal in principal amount to any unpurchased portion of any Notes surrendered; provided that each new Note will be in a
principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. The Company will not be required to make an offer to repurchase the Notes upon a Change of Control Triggering Event if a third party makes such an offer in the manner,
at the times and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment
Date an Event of Default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. 

  
 A-6 

	 	6.	 No Sinking Fund 

The Notes are not entitled to the benefit of any sinking fund. 

 

	 	7.	 Defeasance and Discharge 

The Indenture contains provisions for defeasance and discharge and for defeasance at any time of certain restrictive covenants
and Events of Default with respect to this Note upon compliance with certain conditions set forth in the Indenture. 
  

	 	8.	 Guarantee 

This Note is fully and unconditionally guaranteed by the Guarantor, as provided in Article 14 of the Indenture. 

 

	 	9.	 Modification and Waiver 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights
and obligations of the Company and the Guarantor and the rights of the Holders of the Notes of each series to be affected under the Indenture at any time by the Company, the Guarantor and the Trustee with the consent of the Holders of a majority in
principal amount of the Notes at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes of each series at the time Outstanding, on
behalf of the Holders of all Notes of such series, to waive compliance by the Company and the Guarantor with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the
Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such
consent or waiver is made upon this Note. Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other things, cure any ambiguity, defect or inconsistency, provide for
uncertificated Notes in addition to or in place of certificated Notes, or make any other change that does not adversely affect the rights of any Holder of a Note. 
  

	 	10.	 Events of Default 

If an Event of Default with respect to the Notes shall occur and be continuing, the principal of the Notes may be declared due
and payable in the manner and with the effect provided in the Indenture. 

  
 A-7 

	 	11.	 Remedies 

As provided in and subject to the provisions of the Indenture, the Holder of this Note shall not have the right to institute
any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect
to the Notes of this series, the Holders of not less than 25% in principal amount of the Notes of this series at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default as
Trustee and offered the Trustee reasonable indemnity, and the Trustee shall not have received from the Holders of a majority in principal amount of Notes of this series at the time Outstanding a direction inconsistent with such request, and shall
have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Note for the enforcement of any payment of principal
hereof or any premium or interest hereon on or after the respective due dates expressed herein. 
 No reference herein to the
Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Note at the times, place and rate, and
in the coin or currency, herein prescribed. 
  

	 	12.	 Transfer and Exchange 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Note is registrable in
the Security Register, upon surrender of this Note for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Note are payable, duly endorsed by, or accompanied by a
written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Notes of this series and of like tenor, of
authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 

The Notes of this series are issuable only in registered form without coupons in denominations of $2,000 or an integral
multiple of $1,000 thereof. As provided in the Indenture and subject to certain limitations therein set forth, Notes of this series are exchangeable for a like aggregate principal amount of Notes of this series and of like tenor of a different
authorized denomination, as requested by the Holder surrendering the same. 
 No service charge shall be made for any such
registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Note for registration of transfer, the Company, the Guarantor, the Trustee and any agent of
the Company, the Guarantor or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and none of the Company, the Guarantor, the Trustee nor any such agent
shall be affected by notice to the contrary. 

  
 A-8 

	 	13.	 Governing Law 

THIS NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF NEW YORK, AND FOR ALL PURPOSES SHALL BE
CONSTRUED IN ACCORDANCE WITH THE LAWS OF SAID STATE. FOR THE AVOIDANCE OF DOUBT, THE APPLICABILITY OF ARTICLES 470-3 to 470-19 OF THE LUXEMBOURG LAW DATED
AUGUST 10, 1915 ON COMMERCIAL COMPANIES, AS AMENDED, SHALL BE EXCLUDED. 
  

	 	14.	 Defined Terms 

All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture. As
used in this Note, the term “Predecessor Note” shall have the meaning assigned to the term “Predecessor Security” in the Indenture. 

  
 A-9 

 ASSIGNMENT 
  

			
		 	FOR VALUE RECEIVED, the undersigned assigns and transfers this Note to:
		
		 	  

		
		 	  

		
		 	(Insert assignee’s social security or tax identification number)
		
		 	  

		
		 	  

		
		 	  

		
		 	(Insert address and zip code of assignee) and irrevocably appoints
		
		 	  

		
		 	  

		
		 	  

		
		 	agent to transfer this Note on the books of the Company. The agent may substitute another to act for him or her.
		
		 	 Date:
                            

			
		
		  	 Signature:
                                         
           

		
		  	 Signature Guarantee:
                                   

 (Sign exactly as your name appears on the other side of this Note) 

  
 A-10 

 SIGNATURE GUARANTEE 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Security
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Security Registrar in
addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 A-11 

 SCHEDULE OF INCREASES OR DECREASES IN NOTE 

The initial principal amount of this Note is $            . The following
increases or decreases in the principal amount of this Note have been made: 
  

									
	 Date
	 	 Amount of

decrease in

principal
 amount of
this
 Note
	 	 Amount of

increase in

principal
 amount of
this
 Note
	  	 Principal

amount of this
 Note
following
 such decrease

or increase
	  	 Signature of

authorized
 signatory
of
 Trustee

		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
	  
	 	  
	 	  
	  	  
	  	  

  
 A-12 

 EXHIBIT B 

[IF THIS NOTE IS TO BE A GLOBAL SECURITY, INSERT:] 

UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO
THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS
MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE & CO., HAS AN INTEREST HEREIN. 
 THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED
TO AND IS REGISTERED IN THE NAME OF DTC OR A NOMINEE THEREOF. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN DTC OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND MAY NOT BE
TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC. 
 DH EUROPE FINANCE II
S.À R.L. 
 2.200% Senior Note due 2024 
  

					
	No.                                     	  		  	$                             
			
		  		  	CUSIP: 23291K AG0
		  		  	ISIN: US23291KAG04

 DH Europe Finance II S.à r.l., a private limited liability company
(société à responsabilité limitée) duly organized and existing under the laws of Luxembourg, having its registered office at 1 B Heienhaff, L-1736 Senningerberg, Grand
Duchy of Luxembourg and registered with the Luxembourg Trade and Companies Register under number B 235.237 (herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for
value received, hereby promises to pay to ________________, or registered assigns, the principal sum set forth in the Schedule of Increases or Decreases in Note attached hereto on November 15, 2024, and to pay interest thereon from
November 7, 2019 or from the immediately preceding Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on May 15 and November 15 of each year, commencing May 15, 2020 at the rate
of 2.200% per annum, until the principal hereof is paid or made available for payment. Interest shall be computed on the basis of a 360-day year consisting of twelve
30-day months. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Note (or one or more
Predecessor Notes) is registered on the Security Register at the close of business on the Regular Record Date for such interest, which shall be May 1 or November 1, whether or not a Business Day, immediately preceding the related Interest
Payment Date, except as provided in Section 2.06 of the Supplemental Indenture. 

  
 B-1 

 Any such interest not so punctually paid or duly provided for will forthwith
cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Note (or one or more Predecessor Notes) is registered at the close of business on a Special Record Date for the payment of such
Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of this Note not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of
any securities exchange on which the Notes of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

Payment of the principal of (and premium, if any) and interest on this Note will be made at the office or agency of the Company
maintained for that purpose in accordance with the Indenture, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of
the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or by wire transfer to an account maintained by the Person entitled thereto as specified
in the Security Register. 
 This Note is fully and unconditionally guaranteed by Danaher Corporation, a corporation duly
organized and existing under the laws of the State of Delaware (the “Guarantor”), as provided in the Indenture. 

Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall
for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has
been executed by the Trustee referred to on the reverse hereof by manual signature, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its corporate seal. 

Dated:
                         
  

			
	DH EUROPE FINANCE II S.À R.L.
		
	By:	 	              

	Name:	 	              

	Title:	 	  

  
 B-2 

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Notes of the series designated therein described in the within-mentioned Indenture. 

Dated:
                         

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., 

as Trustee 
 By:
                                        

 Authorized Signatory 

  
 B-3 

 REVERSE OF NOTE 

This Note is one of a duly authorized issue of Securities of the Company (herein called the “Notes”), issued
and to be issued in one or more series under a Base Indenture, dated as of September 18, 2019 (as heretofore supplemented, herein called the “Base Indenture”), among the Company, the Guarantor and The Bank of New York Mellon
Trust Company, N.A., as Trustee (herein called the “Trustee,” which term includes any successor trustee under the Indenture), as supplemented by the Second Supplemental Indenture, dated as of November 7, 2019 (herein called the
“Supplemental Indenture,” which term shall have the meaning assigned to it in such instrument, and together with the Base Indenture, herein called the “Indenture”) and reference is hereby made to the Indenture for a
statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Guarantor, the Trustee and the Holders of the Notes and of the terms upon which the Notes are, and are to be authenticated and delivered.
This Note is one of the series designated on the face hereof initially limited in aggregate principal amount to $700,000,000. The Notes are unsecured general obligations of the Company. 

 

	 	1.	 Optional Redemption 

At any time and from time to time prior to October 15, 2024, the Company shall have the right to redeem the Notes, in
whole or in part, at its option, at a redemption price equal to the greater of: 
 (i)    100% of
the principal amount of the Notes to be redeemed; and 
 (ii)    the sum of the present values of
the Remaining Scheduled Payments on the Notes to be redeemed (not including any portion of the payments of interest that will be accrued and unpaid to and including the Redemption Date) discounted to the Redemption Date on a semi-annual basis
(assuming a 360-day year consisting of twelve 30-day months) at the applicable Treasury Rate plus 10 basis points, plus accrued and unpaid interest, if any, on the
principal amount of the Notes being redeemed to, but excluding, the Redemption Date. 
 On or after October 15, 2024,
the Company shall have the right, at its option, to redeem the Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest,
if any, on the principal amount of the Notes being redeemed to, but excluding, the Redemption Date. 
 The Company will mail
(or send electronically in accordance with applicable Depositary procedures) notice of any redemption to the registered Holders of the Notes to be redeemed not less than 15 nor more than 60 days prior to the Redemption Date. Any notice may, at the
discretion of the Company be subject to the satisfaction or waiver of one or more conditions precedent. In that case, the notice shall state the nature of such condition precedent. If the Notes are only partially redeemed pursuant to
Section 3.01 of the Supplemental Indenture, the Notes to be redeemed will be selected by the Trustee in such manner as in its sole discretion it shall deem appropriate and fair, subject to any applicable Depositary procedures. 

  
 B-4 

 If money sufficient to pay the redemption price of all of the Notes (or a
portion thereof) to be redeemed on the Redemption Date is deposited with the Trustee or Paying Agent on or before the Redemption Date as provided herein and in the Indenture, then on and after such Redemption Date, interest will cease to accrue on
such Notes (or such portion thereof) called for redemption. 
 In the event of redemption of this Note in part only, a new
Note or Notes for the unredeemed portion hereof shall be issued in the name of the Holder hereof upon the cancellation hereof. 
  

	 	2.	 Special Mandatory Redemption 

In the event that the Guarantor does not consummate the GE Biopharma Acquisition on or prior to August 25, 2020 (or such
later date to which the Purchase Agreement may be extended in accordance with its terms) or the Purchase Agreement is terminated at any time prior thereto (or such later date to which the Purchase Agreement may be extended in accordance with
its terms), then the Company must redeem, in whole and not in part, all of the Notes on the Special Mandatory Redemption Date at a redemption price (the “Special Mandatory Redemption Price”) equal to 101% of the aggregate principal
amount of the Notes outstanding, plus accrued and unpaid interest from the most recent Interest Payment Date to which interest has been paid or duly provided for or, if no interest has been paid, from the Issue Date to, but excluding, the Special
Mandatory Redemption Date. 
 The Company will mail notice of such Special Mandatory Redemption, with a copy to the Trustee,
within five Business Days after the occurrence of the event triggering such Special Mandatory Redemption to each Holder of Notes at its registered address. 

If money sufficient to pay the Special Mandatory Redemption Price of all of the Notes to be redeemed on the Special Mandatory
Redemption Date is deposited with the Trustee or Paying Agent on or before the Special Mandatory Redemption Date as provided herein and in the Indenture, then on and after such Special Mandatory Redemption Date, interest will cease to accrue on such
Notes. 
  

	 	3.	 Redemption Upon Changes in Withholding Taxes; Additional Amounts 

The provisions of Sections 1501 and 1502 of the Base Indenture and Sections 2.07 and 3.02 of the Supplemental Indenture shall
apply to this series of Notes. 
 Whenever the payment of the principal of or interest or any other amounts on, or in respect
of, this Note is mentioned, in any context, such mention shall be deemed to include mention of the payment of Additional Amounts to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to the
terms of the Indenture, and express mention of the payment of Additional Amounts in any provision of this series of Notes shall not be construed as excluding the payment of Additional Amounts in those provisions thereof where such express mention is
not made. 

  
 B-5 

	 	4.	 No Other Redemption 

Except as set forth in Sections 1, 2 and 3 of this Note and in Article 3 of the Supplemental Indenture, the Company may not
redeem the Notes prior to the Maturity Date. 
  

	 	5.	 Change of Control Triggering Event 

If a Change of Control Triggering Event occurs, unless the Notes of this series have become redeemable as described in Sections
3.01 and 3.02 of the Supplemental Indenture, Holders of the Notes of this series will have the right to require the Company to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of their Notes pursuant
to the offer described below (the “Change of Control Offer”) on the terms set forth herein. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of
Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased to the date of purchase (the “Change of Control Payment”). Within 30 days following any Change of Control Triggering Event, or, at the
Company’s option, prior to the date of the consummation of any Change of Control, but after public announcement of the transaction that constitutes or may constitute the Change of Control, the Company will be required to mail a notice to
Holders of the Notes, with a copy to the Trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which
date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the “Change of Control Payment Date”), pursuant to the procedures required by the Indenture and described in such notice. The notice
shall, if mailed prior to the date of the consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date. 

On the Change of Control Payment Date, the Company will be required, to the extent lawful, to: 

(i)    accept for payment all of the Notes, or portions of the Notes, properly tendered pursuant to
the Change of Control Offer; 
 (ii)    deposit with the Paying Agent an amount equal to the
Change of Control Payment in respect of all of the Notes, or portions of the Notes, properly tendered; and 

(iii)    deliver or cause to be delivered to the Trustee the Notes properly accepted together with
an Officers’ Certificate stating the aggregate principal amount of Notes, or portions of Notes, being repurchased. 

The Paying Agent will promptly mail to each Holder of Notes properly tendered the Change of Control Payment for such Notes, and
the Trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each such Holder a new Note equal in principal amount to any unpurchased portion of any Notes surrendered; provided that each new Note will be in a
principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. The Company will not be required to make an offer to repurchase the Notes upon a Change of Control Triggering Event if a third party makes such an offer in the manner,
at the times and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

  
 B-6 

 In addition, the Company will not repurchase any Notes if there has occurred
and is continuing on the Change of Control Payment Date an Event of Default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. 

 

	 	6.	 No Sinking Fund 

The Notes are not entitled to the benefit of any sinking fund. 

 

	 	7.	 Defeasance and Discharge 

The Indenture contains provisions for defeasance and discharge and for defeasance at any time of certain restrictive covenants
and Events of Default with respect to this Note upon compliance with certain conditions set forth in the Indenture. 
  

	 	8.	 Guarantee 

This Note is fully and unconditionally guaranteed by the Guarantor, as provided in Article 14 of the Indenture. 

 

	 	9.	 Modification and Waiver 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights
and obligations of the Company and the Guarantor and the rights of the Holders of the Notes of each series to be affected under the Indenture at any time by the Company, the Guarantor and the Trustee with the consent of the Holders of a majority in
principal amount of the Notes at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes of each series at the time Outstanding, on
behalf of the Holders of all Notes of such series, to waive compliance by the Company and the Guarantor with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the
Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such
consent or waiver is made upon this Note. Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other things, cure any ambiguity, defect or inconsistency, provide for
uncertificated Notes in addition to or in place of certificated Notes, or make any other change that does not adversely affect the rights of any Holder of a Note. 
  

	 	10.	 Events of Default 

If an Event of Default with respect to the Notes shall occur and be continuing, the principal of the Notes may be declared due
and payable in the manner and with the effect provided in the Indenture. 

  
 B-7 

	 	11.	 Remedies 

As provided in and subject to the provisions of the Indenture, the Holder of this Note shall not have the right to institute
any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect
to the Notes of this series, the Holders of not less than 25% in principal amount of the Notes of this series at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default as
Trustee and offered the Trustee reasonable indemnity, and the Trustee shall not have received from the Holders of a majority in principal amount of Notes of this series at the time Outstanding a direction inconsistent with such request, and shall
have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Note for the enforcement of any payment of principal
hereof or any premium or interest hereon on or after the respective due dates expressed herein. 
 No reference herein to the
Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Note at the times, place and rate, and
in the coin or currency, herein prescribed. 
  

	 	12.	 Transfer and Exchange 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Note is registrable in
the Security Register, upon surrender of this Note for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Note are payable, duly endorsed by, or accompanied by a
written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Notes of this series and of like tenor, of
authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 

The Notes of this series are issuable only in registered form without coupons in denominations of $2,000 or an integral
multiple of $1,000 thereof. As provided in the Indenture and subject to certain limitations therein set forth, Notes of this series are exchangeable for a like aggregate principal amount of Notes of this series and of like tenor of a different
authorized denomination, as requested by the Holder surrendering the same. 
 No service charge shall be made for any such
registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Note for registration of transfer, the Company, the Guarantor, the Trustee and any agent of
the Company, the Guarantor or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and none of the Company, the Guarantor, the Trustee nor any such agent
shall be affected by notice to the contrary. 

  
 B-8 

	 	13.	 Governing Law 

THIS NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF NEW YORK, AND FOR ALL PURPOSES SHALL BE
CONSTRUED IN ACCORDANCE WITH THE LAWS OF SAID STATE. FOR THE AVOIDANCE OF DOUBT, THE APPLICABILITY OF ARTICLES 470-3 to 470-19 OF THE LUXEMBOURG LAW DATED
AUGUST 10, 1915 ON COMMERCIAL COMPANIES, AS AMENDED, SHALL BE EXCLUDED. 
  

	 	14.	 Defined Terms 

All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture. As
used in this Note, the term “Predecessor Note” shall have the meaning assigned to the term “Predecessor Security” in the Indenture. 

  
 B-9 

 ASSIGNMENT 
  

			
		 	FOR VALUE RECEIVED, the undersigned assigns and transfers this Note to:
		
		 	  

		
		 	  

		
		 	(Insert assignee’s social security or tax identification number)
		
		 	  

		
		 	  

		
		 	  

		
		 	(Insert address and zip code of assignee) and irrevocably appoints
		
		 	  

		
		 	  

		
		 	  

		
		 	agent to transfer this Note on the books of the Company. The agent may substitute another to act for him or her.
		
		 	 Date:
                            

			
		
		  	Signature:
                                         
               
		
		  	Signature Guarantee:
                                       

 (Sign exactly as your name appears on the other side of this Note) 

  
 B-10 

 SIGNATURE GUARANTEE 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Security
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Security Registrar in
addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 B-11 

 SCHEDULE OF INCREASES OR DECREASES IN NOTE 

The initial principal amount of this Note is $            . The following
increases or decreases in the principal amount of this Note have been made: 
  

									
	 Date
	 	 Amount of

decrease in

principal
 amount of
this
 Note
	 	 Amount of

increase in

principal
 amount of
this
 Note
	 	 Principal

amount of this
 Note
following
 such decrease

or increase
	 	 Signature of

authorized
 signatory
of
 Trustee

		 		 		 		 	
		 		 		 		 	
		 		 		 		 	
		 		 		 		 	
		 		 		 		 	
		 		 		 		 	
	  
	 	  
	 	  
	 	  
	 	  

  
 B-12 

 EXHIBIT C 

[IF THIS NOTE IS TO BE A GLOBAL SECURITY, INSERT:] 

UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO
THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS
MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE & CO., HAS AN INTEREST HEREIN. 
 THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED
TO AND IS REGISTERED IN THE NAME OF DTC OR A NOMINEE THEREOF. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN DTC OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND MAY NOT BE
TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC. 
 DH EUROPE FINANCE II
S.À R.L. 
 2.600% Senior Note due 2029 
  

			
	No.                                 	  	$                            
		
	 	  	CUSIP: 23291K AH8
	 	  	ISIN: US23291KAH86

 DH Europe Finance II S.à r.l., a private limited liability company
(société à responsabilité limitée) duly organized and existing under the laws of Luxembourg, having its registered office at 1 B Heienhaff, L-1736 Senningerberg, Grand
Duchy of Luxembourg and registered with the Luxembourg Trade and Companies Register under number B 235.237 (herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for
value received, hereby promises to pay to ________________, or registered assigns, the principal sum set forth in the Schedule of Increases or Decreases in Note attached hereto on November 15, 2029, and to pay interest thereon from
November 7, 2019 or from the immediately preceding Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on May 15 and November 15 of each year, commencing May 15, 2020 at the rate
of 2.600% per annum, until the principal hereof is paid or made available for payment. Interest shall be computed on the basis of a 360-day year consisting of twelve
30-day months. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Note (or one or more
Predecessor Notes) is registered on the Security Register at the close of business on the Regular Record Date for such interest, which shall be May 1 or November 1, whether or not a Business Day, immediately preceding the related Interest
Payment Date, except as provided in Section 2.06 of the Supplemental Indenture. 

  
 C-1 

 Any such interest not so punctually paid or duly provided for will forthwith
cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Note (or one or more Predecessor Notes) is registered at the close of business on a Special Record Date for the payment of such
Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of this Note not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of
any securities exchange on which the Notes of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

Payment of the principal of (and premium, if any) and interest on this Note will be made at the office or agency of the Company
maintained for that purpose in accordance with the Indenture, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of
the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or by wire transfer to an account maintained by the Person entitled thereto as specified
in the Security Register. 
 This Note is fully and unconditionally guaranteed by Danaher Corporation, a corporation duly
organized and existing under the laws of the State of Delaware (the “Guarantor”), as provided in the Indenture. 

Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall
for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has
been executed by the Trustee referred to on the reverse hereof by manual signature, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its corporate seal. 

 

							
	Dated:                         	 		 	
			
		 		 	DH EUROPE FINANCE II S.À R.L.
				
		 		 	By:	 	 
		 		 	Name:	 	 
		 		 	Title: 	 	 

  
 C-2 

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Notes of the series designated therein described in the within-mentioned Indenture. 

Dated:
                             

 

			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,
	
	as Trustee

			
		
	By:	 	 

			
	Authorized Signatory

  
 C-3 

 REVERSE OF NOTE 

This Note is one of a duly authorized issue of Securities of the Company (herein called the “Notes”), issued
and to be issued in one or more series under a Base Indenture, dated as of September 18, 2019 (as heretofore supplemented, herein called the “Base Indenture”), among the Company, the Guarantor and The Bank of New York Mellon
Trust Company, N.A., as Trustee (herein called the “Trustee,” which term includes any successor trustee under the Indenture), as supplemented by the Second Supplemental Indenture, dated as of November 7, 2019 (herein called the
“Supplemental Indenture,” which term shall have the meaning assigned to it in such instrument, and together with the Base Indenture, herein called the “Indenture”) and reference is hereby made to the Indenture for a
statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Guarantor, the Trustee and the Holders of the Notes and of the terms upon which the Notes are, and are to be authenticated and delivered.
This Note is one of the series designated on the face hereof initially limited in aggregate principal amount to $800,000,000. The Notes are unsecured general obligations of the Company. 

 

	 	1.	 Optional Redemption 

At any time and from time to time prior to August 15, 2029, the Company shall have the right to redeem the Notes, in whole
or in part, at its option, at a redemption price equal to the greater of: 
 (i) 100% of the principal amount of the
Notes to be redeemed; and 
 (ii) the sum of the present values of the Remaining Scheduled Payments on the Notes to be
redeemed (not including any portion of the payments of interest that will be accrued and unpaid to and including the Redemption Date) discounted to the Redemption Date on a semi-annual basis (assuming a
360-day year consisting of twelve 30-day months) at the applicable Treasury Rate plus 15 basis points, plus accrued and unpaid interest, if any, on the principal amount
of the Notes being redeemed to, but excluding, the Redemption Date. 
 On or after August 15, 2029, the Company shall
have the right, at its option, to redeem the Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, on the
principal amount of the Notes being redeemed to, but excluding, the Redemption Date. 
 The Company will mail (or send
electronically in accordance with applicable Depositary procedures) notice of any redemption to the registered Holders of the Notes to be redeemed not less than 15 nor more than 60 days prior to the Redemption Date. Any notice may, at the discretion
of the Company be subject to the satisfaction or waiver of one or more conditions precedent. In that case, the notice shall state the nature of such condition precedent. If the Notes are only partially redeemed pursuant to Section 3.01 of the
Supplemental Indenture, the Notes to be redeemed will be selected by the Trustee in such manner as in its sole discretion it shall deem appropriate and fair, subject to any applicable Depositary procedures. 

  
 C-4 

 If money sufficient to pay the redemption price of all of the Notes (or a
portion thereof) to be redeemed on the Redemption Date is deposited with the Trustee or Paying Agent on or before the Redemption Date as provided herein and in the Indenture, then on and after such Redemption Date, interest will cease to accrue on
such Notes (or such portion thereof) called for redemption. 
 In the event of redemption of this Note in part only, a new
Note or Notes for the unredeemed portion hereof shall be issued in the name of the Holder hereof upon the cancellation hereof. 
  

	 	2.	 Special Mandatory Redemption 

In the event that the Guarantor does not consummate the GE Biopharma Acquisition on or prior to August 25, 2020 (or such
later date to which the Purchase Agreement may be extended in accordance with its terms) or the Purchase Agreement is terminated at any time prior thereto (or such later date to which the Purchase Agreement may be extended in accordance with
its terms), then the Company must redeem, in whole and not in part, all of the Notes on the Special Mandatory Redemption Date at a redemption price (the “Special Mandatory Redemption Price”) equal to 101% of the aggregate principal
amount of the Notes outstanding, plus accrued and unpaid interest from the most recent Interest Payment Date to which interest has been paid or duly provided for or, if no interest has been paid, from the Issue Date to, but excluding, the Special
Mandatory Redemption Date. 
 The Company will mail notice of such Special Mandatory Redemption, with a copy to the Trustee,
within five Business Days after the occurrence of the event triggering such Special Mandatory Redemption to each Holder of Notes at its registered address. 

If money sufficient to pay the Special Mandatory Redemption Price of all of the Notes to be redeemed on the Special Mandatory
Redemption Date is deposited with the Trustee or Paying Agent on or before the Special Mandatory Redemption Date as provided herein and in the Indenture, then on and after such Special Mandatory Redemption Date, interest will cease to accrue on such
Notes. 
  

	 	3.	 Redemption Upon Changes in Withholding Taxes; Additional Amounts 

The provisions of Sections 1501 and 1502 of the Base Indenture and Sections 2.07 and 3.02 of the Supplemental Indenture shall
apply to this series of Notes. 
 Whenever the payment of the principal of or interest or any other amounts on, or in respect
of, this Note is mentioned, in any context, such mention shall be deemed to include mention of the payment of Additional Amounts to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to the
terms of the Indenture, and express mention of the payment of Additional Amounts in any provision of this series of Notes shall not be construed as excluding the payment of Additional Amounts in those provisions thereof where such express mention is
not made. 

  
 C-5 

	 	4.	 No Other Redemption 

Except as set forth in Sections 1, 2 and 3 of this Note and in Article 3 of the Supplemental Indenture, the Company may not
redeem the Notes prior to the Maturity Date. 
  

	 	5.	 Change of Control Triggering Event 

If a Change of Control Triggering Event occurs, unless the Notes of this series have become redeemable as described in Sections
3.01 and 3.02 of the Supplemental Indenture, Holders of the Notes of this series will have the right to require the Company to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of their Notes pursuant
to the offer described below (the “Change of Control Offer”) on the terms set forth herein. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of
Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased to the date of purchase (the “Change of Control Payment”). Within 30 days following any Change of Control Triggering Event, or, at the
Company’s option, prior to the date of the consummation of any Change of Control, but after public announcement of the transaction that constitutes or may constitute the Change of Control, the Company will be required to mail a notice to
Holders of the Notes, with a copy to the Trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which
date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the “Change of Control Payment Date”), pursuant to the procedures required by the Indenture and described in such notice. The notice
shall, if mailed prior to the date of the consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date. 

On the Change of Control Payment Date, the Company will be required, to the extent lawful, to: 

(i) accept for payment all of the Notes, or portions of the Notes, properly tendered pursuant to the Change of Control
Offer; 
 (ii) deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all of the
Notes, or portions of the Notes, properly tendered; and 
 (iii) deliver or cause to be delivered to the Trustee the
Notes properly accepted together with an Officers’ Certificate stating the aggregate principal amount of Notes, or portions of Notes, being repurchased. 

The Paying Agent will promptly mail to each Holder of Notes properly tendered the Change of Control Payment for such Notes, and
the Trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each such Holder a new Note equal in principal amount to any unpurchased portion of any Notes surrendered; provided that each new Note will be in a
principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. The Company will not be required to make an offer to repurchase the Notes upon a Change of Control Triggering Event if a third party makes such an offer in the manner,
at the times and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

  
 C-6 

 In addition, the Company will not repurchase any Notes if there has occurred
and is continuing on the Change of Control Payment Date an Event of Default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. 

 

	 	6.	 No Sinking Fund 

The Notes are not entitled to the benefit of any sinking fund. 

 

	 	7.	 Defeasance and Discharge 

The Indenture contains provisions for defeasance and discharge and for defeasance at any time of certain restrictive covenants
and Events of Default with respect to this Note upon compliance with certain conditions set forth in the Indenture. 
  

	 	8.	 Guarantee 

This Note is fully and unconditionally guaranteed by the Guarantor, as provided in Article 14 of the Indenture. 

 

	 	9.	 Modification and Waiver 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights
and obligations of the Company and the Guarantor and the rights of the Holders of the Notes of each series to be affected under the Indenture at any time by the Company, the Guarantor and the Trustee with the consent of the Holders of a majority in
principal amount of the Notes at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes of each series at the time Outstanding, on
behalf of the Holders of all Notes of such series, to waive compliance by the Company and the Guarantor with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the
Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such
consent or waiver is made upon this Note. Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other things, cure any ambiguity, defect or inconsistency, provide for
uncertificated Notes in addition to or in place of certificated Notes, or make any other change that does not adversely affect the rights of any Holder of a Note. 
  

	 	10.	 Events of Default 

If an Event of Default with respect to the Notes shall occur and be continuing, the principal of the Notes may be declared due
and payable in the manner and with the effect provided in the Indenture. 

  
 C-7 

	 	11.	 Remedies 

As provided in and subject to the provisions of the Indenture, the Holder of this Note shall not have the right to institute
any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect
to the Notes of this series, the Holders of not less than 25% in principal amount of the Notes of this series at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default as
Trustee and offered the Trustee reasonable indemnity, and the Trustee shall not have received from the Holders of a majority in principal amount of Notes of this series at the time Outstanding a direction inconsistent with such request, and shall
have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Note for the enforcement of any payment of principal
hereof or any premium or interest hereon on or after the respective due dates expressed herein. 
 No reference herein to the
Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Note at the times, place and rate, and
in the coin or currency, herein prescribed. 
  

	 	12.	 Transfer and Exchange 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Note is registrable in
the Security Register, upon surrender of this Note for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Note are payable, duly endorsed by, or accompanied by a
written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Notes of this series and of like tenor, of
authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 

The Notes of this series are issuable only in registered form without coupons in denominations of $2,000 or an integral
multiple of $1,000 thereof. As provided in the Indenture and subject to certain limitations therein set forth, Notes of this series are exchangeable for a like aggregate principal amount of Notes of this series and of like tenor of a different
authorized denomination, as requested by the Holder surrendering the same. 
 No service charge shall be made for any such
registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Note for registration of transfer, the Company, the Guarantor, the Trustee and any agent of
the Company, the Guarantor or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and none of the Company, the Guarantor, the Trustee nor any such agent
shall be affected by notice to the contrary. 

  
 C-8 

	 	13.	 Governing Law 

THIS NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF NEW YORK, AND FOR ALL PURPOSES SHALL BE
CONSTRUED IN ACCORDANCE WITH THE LAWS OF SAID STATE. FOR THE AVOIDANCE OF DOUBT, THE APPLICABILITY OF ARTICLES 470-3 to 470-19 OF THE LUXEMBOURG LAW DATED
AUGUST 10, 1915 ON COMMERCIAL COMPANIES, AS AMENDED, SHALL BE EXCLUDED. 
  

	 	14.	 Defined Terms 

All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture. As
used in this Note, the term “Predecessor Note” shall have the meaning assigned to the term “Predecessor Security” in the Indenture. 

  
 C-9 

 ASSIGNMENT 
  

			
		 	FOR VALUE RECEIVED, the undersigned assigns and transfers this Note to:
		
		 	  

		
		 	  

		
		 	(Insert assignee’s social security or tax identification number)
		
		 	  

		
		 	  

		
		 	  

		
		 	(Insert address and zip code of assignee) and irrevocably appoints
		
		 	  

		
		 	  

		
		 	  

		
		 	agent to transfer this Note on the books of the Company. The agent may substitute another to act for him or her.
		
		 	 Date:
                            

			
		
		  	 Signature:
                                         
           

		
		  	 Signature Guarantee:
                                   

 (Sign exactly as your name appears on the other side of this Note) 

  
 C-10 

 SIGNATURE GUARANTEE 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Security
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Security Registrar in
addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 C-11 

 SCHEDULE OF INCREASES OR DECREASES IN NOTE 

The initial principal amount of this Note is $            . The following
increases or decreases in the principal amount of this Note have been made: 
  

									
	 Date
	 	 Amount of

decrease in

principal
 amount of
this
 Note
	 	 Amount of

increase in

principal
 amount of
this
 Note
	  	 Principal

amount of this
 Note
following
 such decrease

or increase
	  	 Signature of

authorized
 signatory
of
 Trustee

		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
	  
	 	  
	 	  
	  	  
	  	  

  
 C-12 

 EXHIBIT D 

[IF THIS NOTE IS TO BE A GLOBAL SECURITY, INSERT:] 

UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO
THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS
MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE & CO., HAS AN INTEREST HEREIN. 
 THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED
TO AND IS REGISTERED IN THE NAME OF DTC OR A NOMINEE THEREOF. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN DTC OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND MAY NOT BE
TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC. 
 DH EUROPE FINANCE II
S.À R.L. 
 3.250% Senior Note due 2039 
  

					
	No.                                     	  		  	$                             
			
		  		  	CUSIP: 23291K AJ4
		  		  	ISIN: US23291KAJ43

 DH Europe Finance II S.à r.l., a private limited liability company
(société à responsabilité limitée) duly organized and existing under the laws of Luxembourg, having its registered office at 1 B Heienhaff, L-1736 Senningerberg, Grand
Duchy of Luxembourg and registered with the Luxembourg Trade and Companies Register under number B 235.237 (herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for
value received, hereby promises to pay to ________________, or registered assigns, the principal sum set forth in the Schedule of Increases or Decreases in Note attached hereto on November 15, 2039, and to pay interest thereon from
November 7, 2019 or from the immediately preceding Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on May 15 and November 15 of each year, commencing May 15, 2020 at the rate
of 3.250% per annum, until the principal hereof is paid or made available for payment. Interest shall be computed on the basis of a 360-day year consisting of twelve
30-day months. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Note (or one or more
Predecessor Notes) is registered on the Security Register at the close of business on the Regular Record Date for such interest, which shall be May 1 or November 1, whether or not a Business Day, immediately preceding the related Interest
Payment Date, except as provided in Section 2.06 of the Supplemental Indenture. 

  
 D-1 

 Any such interest not so punctually paid or duly provided for will forthwith
cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Note (or one or more Predecessor Notes) is registered at the close of business on a Special Record Date for the payment of such
Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of this Note not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of
any securities exchange on which the Notes of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

Payment of the principal of (and premium, if any) and interest on this Note will be made at the office or agency of the Company
maintained for that purpose in accordance with the Indenture, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of
the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or by wire transfer to an account maintained by the Person entitled thereto as specified
in the Security Register. 
 This Note is fully and unconditionally guaranteed by Danaher Corporation, a corporation duly
organized and existing under the laws of the State of Delaware (the “Guarantor”), as provided in the Indenture. 

Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall
for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has
been executed by the Trustee referred to on the reverse hereof by manual signature, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its corporate seal. 

Dated:
                             

 

			
	DH EUROPE FINANCE II S.À R.L.
		
	By:	 	              

	Name:	 	              

	Title:	 	  

  
 D-2 

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Notes of the series designated therein described in the within-mentioned Indenture. 

Dated:
                         

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., 

as Trustee 
 By:
                                        

 Authorized Signatory 

  
 D-3 

 REVERSE OF NOTE 

This Note is one of a duly authorized issue of Securities of the Company (herein called the “Notes”), issued
and to be issued in one or more series under a Base Indenture, dated as of September 18, 2019 (as heretofore supplemented, herein called the “Base Indenture”), among the Company, the Guarantor and The Bank of New York Mellon
Trust Company, N.A., as Trustee (herein called the “Trustee,” which term includes any successor trustee under the Indenture), as supplemented by the Second Supplemental Indenture, dated as of November 7, 2019 (herein called the
“Supplemental Indenture,” which term shall have the meaning assigned to it in such instrument, and together with the Base Indenture, herein called the “Indenture”) and reference is hereby made to the Indenture for a
statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Guarantor, the Trustee and the Holders of the Notes and of the terms upon which the Notes are, and are to be authenticated and delivered.
This Note is one of the series designated on the face hereof initially limited in aggregate principal amount to $900,000,000. The Notes are unsecured general obligations of the Company. 

 

	 	1.	 Optional Redemption 

At any time and from time to time prior to May 15, 2039, the Company shall have the right to redeem the Notes, in whole or
in part, at its option, at a redemption price equal to the greater of: 
 (i)    100% of the
principal amount of the Notes to be redeemed; and 
 (ii)    the sum of the present values of the
Remaining Scheduled Payments on the Notes to be redeemed (not including any portion of the payments of interest that will be accrued and unpaid to and including the Redemption Date) discounted to the Redemption Date on a semi-annual basis (assuming
a 360-day year consisting of twelve 30-day months) at the applicable Treasury Rate plus 15 basis points, plus accrued and unpaid interest, if any, on the principal
amount of the Notes being redeemed to, but excluding, the Redemption Date. 
 On or after May 15, 2039, the Company
shall have the right, at its option, to redeem the Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, on
the principal amount of the Notes being redeemed to, but excluding, the Redemption Date. 
 The Company will mail (or send
electronically in accordance with applicable Depositary procedures) notice of any redemption to the registered Holders of the Notes to be redeemed not less than 15 nor more than 60 days prior to the Redemption Date. Any notice may, at the discretion
of the Company be subject to the satisfaction or waiver of one or more conditions precedent. In that case, the notice shall state the nature of such condition precedent. If the Notes are only partially redeemed pursuant to Section 3.01 of the
Supplemental Indenture, the Notes to be redeemed will be selected by the Trustee in such manner as in its sole discretion it shall deem appropriate and fair, subject to any applicable Depositary procedures. 

  
 D-4 

 If money sufficient to pay the redemption price of all of the Notes (or a
portion thereof) to be redeemed on the Redemption Date is deposited with the Trustee or Paying Agent on or before the Redemption Date as provided herein and in the Indenture, then on and after such Redemption Date, interest will cease to accrue on
such Notes (or such portion thereof) called for redemption. 
 In the event of redemption of this Note in part only, a new
Note or Notes for the unredeemed portion hereof shall be issued in the name of the Holder hereof upon the cancellation hereof. 
  

	 	2.	 Special Mandatory Redemption 

In the event that the Guarantor does not consummate the GE Biopharma Acquisition on or prior to August 25, 2020 (or such
later date to which the Purchase Agreement may be extended in accordance with its terms) or the Purchase Agreement is terminated at any time prior thereto (or such later date to which the Purchase Agreement may be extended in accordance with
its terms), then the Company must redeem, in whole and not in part, all of the Notes on the Special Mandatory Redemption Date at a redemption price (the “Special Mandatory Redemption Price”) equal to 101% of the aggregate principal
amount of the Notes outstanding, plus accrued and unpaid interest from the most recent Interest Payment Date to which interest has been paid or duly provided for or, if no interest has been paid, from the Issue Date to, but excluding, the Special
Mandatory Redemption Date. 
 The Company will mail notice of such Special Mandatory Redemption, with a copy to the Trustee,
within five Business Days after the occurrence of the event triggering such Special Mandatory Redemption to each Holder of Notes at its registered address. 

If money sufficient to pay the Special Mandatory Redemption Price of all of the Notes to be redeemed on the Special Mandatory
Redemption Date is deposited with the Trustee or Paying Agent on or before the Special Mandatory Redemption Date as provided herein and in the Indenture, then on and after such Special Mandatory Redemption Date, interest will cease to accrue on such
Notes. 
  

	 	3.	 Redemption Upon Changes in Withholding Taxes; Additional Amounts 

The provisions of Sections 1501 and 1502 of the Base Indenture and Sections 2.07 and 3.02 of the Supplemental Indenture shall
apply to this series of Notes. 
 Whenever the payment of the principal of or interest or any other amounts on, or in
respect of, this Note is mentioned, in any context, such mention shall be deemed to include mention of the payment of Additional Amounts to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof
pursuant to the terms of the Indenture, and express mention of the payment of Additional Amounts in any provision of this series of Notes shall not be construed as excluding the payment of Additional Amounts in those provisions thereof where such
express mention is not made. 

  
 D-5 

	 	4.	 No Other Redemption 

Except as set forth in Sections 1, 2 and 3 of this Note and in Article 3 of the Supplemental Indenture, the Company may not
redeem the Notes prior to the Maturity Date. 
  

	 	5.	 Change of Control Triggering Event 

If a Change of Control Triggering Event occurs, unless the Notes of this series have become redeemable as described in Sections
3.01 and 3.02 of the Supplemental Indenture, Holders of the Notes of this series will have the right to require the Company to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of their Notes pursuant
to the offer described below (the “Change of Control Offer”) on the terms set forth herein. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of
Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased to the date of purchase (the “Change of Control Payment”). Within 30 days following any Change of Control Triggering Event, or, at the
Company’s option, prior to the date of the consummation of any Change of Control, but after public announcement of the transaction that constitutes or may constitute the Change of Control, the Company will be required to mail a notice to
Holders of the Notes, with a copy to the Trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which
date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the “Change of Control Payment Date”), pursuant to the procedures required by the Indenture and described in such notice. The notice
shall, if mailed prior to the date of the consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date. 

On the Change of Control Payment Date, the Company will be required, to the extent lawful, to: 

(i)    accept for payment all of the Notes, or portions of the Notes, properly tendered pursuant to
the Change of Control Offer; 
 (ii)    deposit with the Paying Agent an amount equal to the
Change of Control Payment in respect of all of the Notes, or portions of the Notes, properly tendered; and 

(iii)    deliver or cause to be delivered to the Trustee the Notes properly accepted together with
an Officers’ Certificate stating the aggregate principal amount of Notes, or portions of Notes, being repurchased. 

The Paying Agent will promptly mail to each Holder of Notes properly tendered the Change of Control Payment for such Notes, and
the Trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each such Holder a new Note equal in principal amount to any unpurchased portion of any Notes surrendered; provided that each new Note will be in a
principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. The Company will not be required to make an offer to repurchase the Notes upon a Change of Control Triggering Event if a third party makes such an offer in the manner,
at the times and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

  
 D-6 

 In addition, the Company will not repurchase any Notes if there has occurred
and is continuing on the Change of Control Payment Date an Event of Default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. 

 

	 	6.    No	 Sinking Fund 

The Notes are not entitled to the benefit of any sinking fund. 

 

	 	7.    Defeasance	 and Discharge 

The Indenture contains provisions for defeasance and discharge and for defeasance at any time of certain restrictive covenants
and Events of Default with respect to this Note upon compliance with certain conditions set forth in the Indenture. 
  

	 	8.    Guarantee	 

This Note is fully and unconditionally guaranteed by the Guarantor, as provided in Article 14 of the Indenture. 

 

	 	9.    Modification	 and Waiver 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights
and obligations of the Company and the Guarantor and the rights of the Holders of the Notes of each series to be affected under the Indenture at any time by the Company, the Guarantor and the Trustee with the consent of the Holders of a majority in
principal amount of the Notes at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes of each series at the time Outstanding, on
behalf of the Holders of all Notes of such series, to waive compliance by the Company and the Guarantor with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the
Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such
consent or waiver is made upon this Note. Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other things, cure any ambiguity, defect or inconsistency, provide for
uncertificated Notes in addition to or in place of certificated Notes, or make any other change that does not adversely affect the rights of any Holder of a Note. 
  

	 	10.    Events	 of Default 

If an Event of Default with respect to the Notes shall occur and be continuing, the principal of the Notes may be declared due
and payable in the manner and with the effect provided in the Indenture. 

  
 D-7 

	 	11.	 Remedies 

As provided in and subject to the provisions of the Indenture, the Holder of this Note shall not have the right to institute
any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect
to the Notes of this series, the Holders of not less than 25% in principal amount of the Notes of this series at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default as
Trustee and offered the Trustee reasonable indemnity, and the Trustee shall not have received from the Holders of a majority in principal amount of Notes of this series at the time Outstanding a direction inconsistent with such request, and shall
have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Note for the enforcement of any payment of principal
hereof or any premium or interest hereon on or after the respective due dates expressed herein. 
 No reference herein to the
Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Note at the times, place and rate, and
in the coin or currency, herein prescribed. 
  

	 	12.	 Transfer and Exchange 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Note is registrable in
the Security Register, upon surrender of this Note for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Note are payable, duly endorsed by, or accompanied by a
written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Notes of this series and of like tenor, of
authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 

The Notes of this series are issuable only in registered form without coupons in denominations of $2,000 or an integral
multiple of $1,000 thereof. As provided in the Indenture and subject to certain limitations therein set forth, Notes of this series are exchangeable for a like aggregate principal amount of Notes of this series and of like tenor of a different
authorized denomination, as requested by the Holder surrendering the same. 
 No service charge shall be made for any such
registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Note for registration of transfer, the Company, the Guarantor, the Trustee and any agent of
the Company, the Guarantor or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and none of the Company, the Guarantor, the Trustee nor any such agent
shall be affected by notice to the contrary. 

  
 D-8 

	 	13.	 Governing Law 

THIS NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF NEW YORK, AND FOR ALL PURPOSES SHALL BE
CONSTRUED IN ACCORDANCE WITH THE LAWS OF SAID STATE. FOR THE AVOIDANCE OF DOUBT, THE APPLICABILITY OF ARTICLES 470-3 to 470-19 OF THE LUXEMBOURG LAW DATED
AUGUST 10, 1915 ON COMMERCIAL COMPANIES, AS AMENDED, SHALL BE EXCLUDED. 
  

	 	14.	 Defined Terms 

All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture. As
used in this Note, the term “Predecessor Note” shall have the meaning assigned to the term “Predecessor Security” in the Indenture. 

  
 D-9 

 ASSIGNMENT 
  

			
		 	FOR VALUE RECEIVED, the undersigned assigns and transfers this Note to:
		
		 	  

		
		 	  

		
		 	(Insert assignee’s social security or tax identification number)
		
		 	  

		
		 	  

		
		 	  

		
		 	(Insert address and zip code of assignee) and irrevocably appoints
		
		 	  

		
		 	  

		
		 	  

		
		 	agent to transfer this Note on the books of the Company. The agent may substitute another to act for him or her.
		
		 	 Date:
                            

			
		
		  	 Signature:
                                         
           

		
		  	 Signature Guarantee:
                                   

 (Sign exactly as your name appears on the other side of this Note) 

  
 D-10 

 SIGNATURE GUARANTEE 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Security
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Security Registrar in
addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 D-11 

 SCHEDULE OF INCREASES OR DECREASES IN NOTE 

The initial principal amount of this Note is $            . The following
increases or decreases in the principal amount of this Note have been made: 
  

									
	 Date
	 	 Amount of

decrease in

principal
 amount of
this
 Note
	 	 Amount of

increase in

principal
 amount of
this
 Note
	  	 Principal

amount of this
 Note
following
 such decrease

or increase
	  	 Signature of

authorized
 signatory
of
 Trustee

		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
	  
	 	  
	 	  
	  	  
	  	  

  
 D-12 

 EXHIBIT E 

[IF THIS NOTE IS TO BE A GLOBAL SECURITY, INSERT:] 

UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO
THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS
MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE & CO., HAS AN INTEREST HEREIN. 
 THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED
TO AND IS REGISTERED IN THE NAME OF DTC OR A NOMINEE THEREOF. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN DTC OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND MAY NOT BE
TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC. 
 DH EUROPE FINANCE II
S.À R.L. 
 3.400% Senior Note due 2049 
  

					
	No.                                     	  		  	$                             
			
		  		  	CUSIP: 23291K AK1
		  		  	ISIN: US23291KAJ43

 DH Europe Finance II S.à r.l., a private limited liability company
(société à responsabilité limitée) duly organized and existing under the laws of Luxembourg, having its registered office at 1 B Heienhaff, L-1736 Senningerberg, Grand
Duchy of Luxembourg and registered with the Luxembourg Trade and Companies Register under number B 235.237 (herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for
value received, hereby promises to pay to ________________, or registered assigns, the principal sum set forth in the Schedule of Increases or Decreases in Note attached hereto on November 15, 2049, and to pay interest thereon from
November 7, 2019 or from the immediately preceding Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on May 15 and November 15 of each year, commencing May 15, 2020 at the rate
of 3.400% per annum, until the principal hereof is paid or made available for payment. Interest shall be computed on the basis of a 360-day year consisting of twelve
30-day months. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Note (or one or more
Predecessor Notes) is registered on the Security Register at the close of business on the Regular Record Date for such interest, which shall be May 1 or November 1, whether or not a Business Day, immediately preceding the related Interest
Payment Date, except as provided in Section 2.06 of the Supplemental Indenture. 

  
 E-1 

 Any such interest not so punctually paid or duly provided for will forthwith
cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Note (or one or more Predecessor Notes) is registered at the close of business on a Special Record Date for the payment of such
Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of this Note not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of
any securities exchange on which the Notes of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

Payment of the principal of (and premium, if any) and interest on this Note will be made at the office or agency of the Company
maintained for that purpose in accordance with the Indenture, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of
the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or by wire transfer to an account maintained by the Person entitled thereto as specified
in the Security Register. 
 This Note is fully and unconditionally guaranteed by Danaher Corporation, a corporation duly
organized and existing under the laws of the State of Delaware (the “Guarantor”), as provided in the Indenture. 

Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall
for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has
been executed by the Trustee referred to on the reverse hereof by manual signature, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its corporate seal. 

Dated:
                         

 

			
	DH EUROPE FINANCE II S.À R.L.
		
	By:	 	              

	Name:	 	              

	Title:	 	  

  
 E-2 

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Notes of the series designated therein described in the within-mentioned Indenture. 

Dated:
                         

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., 

as Trustee 
 By:
                                         
    
 Authorized Signatory 

  
 E-3 

 REVERSE OF NOTE 

This Note is one of a duly authorized issue of Securities of the Company (herein called the “Notes”), issued
and to be issued in one or more series under a Base Indenture, dated as of September 18, 2019 (as heretofore supplemented, herein called the “Base Indenture”), among the Company, the Guarantor and The Bank of New York Mellon
Trust Company, N.A., as Trustee (herein called the “Trustee,” which term includes any successor trustee under the Indenture), as supplemented by the Second Supplemental Indenture, dated as of November 7, 2019 (herein called the
“Supplemental Indenture,” which term shall have the meaning assigned to it in such instrument, and together with the Base Indenture, herein called the “Indenture”) and reference is hereby made to the Indenture for a
statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Guarantor, the Trustee and the Holders of the Notes and of the terms upon which the Notes are, and are to be authenticated and delivered.
This Note is one of the series designated on the face hereof initially limited in aggregate principal amount to $900,000,000. The Notes are unsecured general obligations of the Company. 

 

	 	1.	 Optional Redemption 

At any time and from time to time prior to May 15, 2049, the Company shall have the right to redeem the Notes, in whole or
in part, at its option, at a redemption price equal to the greater of: 
 (i) 100% of the principal amount of the
Notes to be redeemed; and 
 (ii) the sum of the present values of the Remaining Scheduled Payments on the Notes to be
redeemed (not including any portion of the payments of interest that will be accrued and unpaid to and including the Redemption Date) discounted to the Redemption Date on a semi-annual basis (assuming a
360-day year consisting of twelve 30-day months) at the applicable Treasury Rate plus 20 basis points, plus accrued and unpaid interest, if any, on the principal amount
of the Notes being redeemed to, but excluding, the Redemption Date. 
 On or after May 15, 2049, the Company shall have
the right, at its option, to redeem the Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, on the
principal amount of the Notes being redeemed to, but excluding, the Redemption Date. 
 The Company will mail (or send
electronically in accordance with applicable Depositary procedures) notice of any redemption to the registered Holders of the Notes to be redeemed not less than 15 nor more than 60 days prior to the Redemption Date. Any notice may, at the discretion
of the Company be subject to the satisfaction or waiver of one or more conditions precedent. In that case, the notice shall state the nature of such condition precedent. If the Notes are only partially redeemed pursuant to Section 3.01 of the
Supplemental Indenture, the Notes to be redeemed will be selected by the Trustee in such manner as in its sole discretion it shall deem appropriate and fair, subject to any applicable Depositary procedures. 

  
 E-4 

 If money sufficient to pay the redemption price of all of the Notes (or a
portion thereof) to be redeemed on the Redemption Date is deposited with the Trustee or Paying Agent on or before the Redemption Date as provided herein and in the Indenture, then on and after such Redemption Date, interest will cease to accrue on
such Notes (or such portion thereof) called for redemption. 
 In the event of redemption of this Note in part only, a new
Note or Notes for the unredeemed portion hereof shall be issued in the name of the Holder hereof upon the cancellation hereof. 
  

	 	2.	 Special Mandatory Redemption 

In the event that the Guarantor does not consummate the GE Biopharma Acquisition on or prior to August 25, 2020 (or such
later date to which the Purchase Agreement may be extended in accordance with its terms) or the Purchase Agreement is terminated at any time prior thereto (or such later date to which the Purchase Agreement may be extended in accordance with
its terms), then the Company must redeem, in whole and not in part, all of the Notes on the Special Mandatory Redemption Date at a redemption price (the “Special Mandatory Redemption Price”) equal to 101% of the aggregate principal
amount of the Notes outstanding, plus accrued and unpaid interest from the most recent Interest Payment Date to which interest has been paid or duly provided for or, if no interest has been paid, from the Issue Date to, but excluding, the Special
Mandatory Redemption Date. 
 The Company will mail notice of such Special Mandatory Redemption, with a copy to the Trustee,
within five Business Days after the occurrence of the event triggering such Special Mandatory Redemption to each Holder of Notes at its registered address. 

If money sufficient to pay the Special Mandatory Redemption Price of all of the Notes to be redeemed on the Special Mandatory
Redemption Date is deposited with the Trustee or Paying Agent on or before the Special Mandatory Redemption Date as provided herein and in the Indenture, then on and after such Special Mandatory Redemption Date, interest will cease to accrue on such
Notes. 
  

	 	3.	 Redemption Upon Changes in Withholding Taxes; Additional Amounts 

The provisions of Sections 1501 and 1502 of the Base Indenture and Sections 2.07 and 3.02 of the Supplemental Indenture shall
apply to this series of Notes. 
 Whenever the payment of the principal of or interest or any other amounts on, or in respect
of, this Note is mentioned, in any context, such mention shall be deemed to include mention of the payment of Additional Amounts to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to the
terms of the Indenture, and express mention of the payment of Additional Amounts in any provision of this series of Notes shall not be construed as excluding the payment of Additional Amounts in those provisions thereof where such express mention is
not made. 

  
 E-5 

	 	4.	 No Other Redemption 

Except as set forth in Sections 1, 2 and 3 of this Note and in Article 3 of the Supplemental Indenture, the Company may not
redeem the Notes prior to the Maturity Date. 
  

	 	5.	 Change of Control Triggering Event 

If a Change of Control Triggering Event occurs, unless the Notes of this series have become redeemable as described in Sections
3.01 and 3.02 of the Supplemental Indenture, Holders of the Notes of this series will have the right to require the Company to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of their Notes pursuant
to the offer described below (the “Change of Control Offer”) on the terms set forth herein. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of
Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased to the date of purchase (the “Change of Control Payment”). Within 30 days following any Change of Control Triggering Event, or, at the
Company’s option, prior to the date of the consummation of any Change of Control, but after public announcement of the transaction that constitutes or may constitute the Change of Control, the Company will be required to mail a notice to
Holders of the Notes, with a copy to the Trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which
date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the “Change of Control Payment Date”), pursuant to the procedures required by the Indenture and described in such notice. The notice
shall, if mailed prior to the date of the consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date. 

On the Change of Control Payment Date, the Company will be required, to the extent lawful, to: 

(i) accept for payment all of the Notes, or portions of the Notes, properly tendered pursuant to the Change of Control
Offer; 
 (ii) deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all of the
Notes, or portions of the Notes, properly tendered; and 
 (iii) deliver or cause to be delivered to the Trustee the
Notes properly accepted together with an Officers’ Certificate stating the aggregate principal amount of Notes, or portions of Notes, being repurchased. 

The Paying Agent will promptly mail to each Holder of Notes properly tendered the Change of Control Payment for such Notes, and
the Trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each such Holder a new Note equal in principal amount to any unpurchased portion of any Notes surrendered; provided that each new Note will be in a
principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. The Company will not be required to make an offer to repurchase the Notes upon a Change of Control Triggering Event if a third party makes such an offer in the manner,
at the times and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

  
 E-6 

 In addition, the Company will not repurchase any Notes if there has occurred
and is continuing on the Change of Control Payment Date an Event of Default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. 

 

	 	6.	 No Sinking Fund 

The Notes are not entitled to the benefit of any sinking fund. 

 

	 	7.	 Defeasance and Discharge 

The Indenture contains provisions for defeasance and discharge and for defeasance at any time of certain restrictive covenants
and Events of Default with respect to this Note upon compliance with certain conditions set forth in the Indenture. 
  

	 	8.	 Guarantee 

This Note is fully and unconditionally guaranteed by the Guarantor, as provided in Article 14 of the Indenture. 

 

	 	9.	 Modification and Waiver 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights
and obligations of the Company and the Guarantor and the rights of the Holders of the Notes of each series to be affected under the Indenture at any time by the Company, the Guarantor and the Trustee with the consent of the Holders of a majority in
principal amount of the Notes at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes of each series at the time Outstanding, on
behalf of the Holders of all Notes of such series, to waive compliance by the Company and the Guarantor with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the
Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such
consent or waiver is made upon this Note. Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other things, cure any ambiguity, defect or inconsistency, provide for
uncertificated Notes in addition to or in place of certificated Notes, or make any other change that does not adversely affect the rights of any Holder of a Note. 
  

	 	10.	 Events of Default 

If an Event of Default with respect to the Notes shall occur and be continuing, the principal of the Notes may be declared due
and payable in the manner and with the effect provided in the Indenture. 

  
 E-7 

	 	11.	 Remedies 

As provided in and subject to the provisions of the Indenture, the Holder of this Note shall not have the right to institute
any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect
to the Notes of this series, the Holders of not less than 25% in principal amount of the Notes of this series at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default as
Trustee and offered the Trustee reasonable indemnity, and the Trustee shall not have received from the Holders of a majority in principal amount of Notes of this series at the time Outstanding a direction inconsistent with such request, and shall
have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Note for the enforcement of any payment of principal
hereof or any premium or interest hereon on or after the respective due dates expressed herein. 
 No reference herein to
the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Note at the times, place and rate,
and in the coin or currency, herein prescribed. 
  

	 	12.	 Transfer and Exchange 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Note is registrable in
the Security Register, upon surrender of this Note for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Note are payable, duly endorsed by, or accompanied by a
written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Notes of this series and of like tenor, of
authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 

The Notes of this series are issuable only in registered form without coupons in denominations of $2,000 or an integral
multiple of $1,000 thereof. As provided in the Indenture and subject to certain limitations therein set forth, Notes of this series are exchangeable for a like aggregate principal amount of Notes of this series and of like tenor of a different
authorized denomination, as requested by the Holder surrendering the same. 
 No service charge shall be made for any such
registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Note for registration of transfer, the Company, the Guarantor, the Trustee and any agent of
the Company, the Guarantor or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and none of the Company, the Guarantor, the Trustee nor any such agent
shall be affected by notice to the contrary. 

  
 E-8 

	 	13.	 Governing Law 

THIS NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF NEW YORK, AND FOR ALL PURPOSES SHALL BE
CONSTRUED IN ACCORDANCE WITH THE LAWS OF SAID STATE. FOR THE AVOIDANCE OF DOUBT, THE APPLICABILITY OF ARTICLES 470-3 to 470-19 OF THE LUXEMBOURG LAW DATED
AUGUST 10, 1915 ON COMMERCIAL COMPANIES, AS AMENDED, SHALL BE EXCLUDED. 
  

	 	14.	 Defined Terms 

All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture. As
used in this Note, the term “Predecessor Note” shall have the meaning assigned to the term “Predecessor Security” in the Indenture. 

  
 E-9 

 ASSIGNMENT 
  

			
		 	FOR VALUE RECEIVED, the undersigned assigns and transfers this Note to:
		
		 	  

		
		 	  

		
		 	(Insert assignee’s social security or tax identification number)
		
		 	  

		
		 	  

		
		 	  

		
		 	(Insert address and zip code of assignee) and irrevocably appoints
		
		 	  

		
		 	  

		
		 	  

		
		 	agent to transfer this Note on the books of the Company. The agent may substitute another to act for him or her.
		
		 	 Date:
                            

			
		
		  	 Signature:
                                         
           

		
		  	 Signature Guarantee:
                                   

 (Sign exactly as your name appears on the other side of this Note) 

  
 E-10 

 SIGNATURE GUARANTEE 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Security
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Security Registrar in
addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 E-11 

 SCHEDULE OF INCREASES OR DECREASES IN NOTE 

The initial principal amount of this Note is $            . The following
increases or decreases in the principal amount of this Note have been made: 
  

									
	 Date
	 	 Amount of

decrease in

principal
 amount of
this
 Note
	 	 Amount of

increase in

principal
 amount of
this
 Note
	  	 Principal

amount of this
 Note
following
 such decrease

or increase
	  	 Signature of

authorized
 signatory
of
 Trustee

		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
		 		 		  		  	
	  
	 	  
	 	  
	  	  
	  	  

  
 E-12 

 EXHIBIT F 

[FORM OF GUARANTEE] 
 GUARANTEE

 For value received, the undersigned (the “Guarantor”), to the extent set forth in and subject to the
terms of the Indenture, dated as of September 18, 2019 (as heretofore supplemented, the “Base Indenture”), among DH Europe Finance II S.à r.l., a private limited liability company, société à
responsabilité limitée, duly organized and existing under the laws of Luxembourg, having its registered office at 1 B Heienhaff, L-1736 Senningerberg, Grand Duchy of Luxembourg and registered
with the Luxembourg Trade and Companies Register under number B 235.237 (the “Company”), the Guarantor and The Bank of New York Mellon Trust Company, N.A., as Trustee (herein called the Trustee, which term includes any successor
trustee under the Indenture) and the Second Supplemental Indenture, among the Company, the Guarantor and the Trustee (the “Supplemental Indenture,” and together with the Base Indenture, the “Indenture”), irrevocably
and unconditionally guarantees to each Holder and to the Trustee and its successors and assigns (1) the full and punctual payment when due, whether at Stated Maturity, by acceleration, by redemption or otherwise, of all obligations of the
Company under the Indenture (including obligations to the Trustee) and the Notes, whether for payment of principal of, interest on, premium, if any, or Additional Amounts, if any, on the Notes and all other monetary obligations of the Company under
the Indenture and the Notes and (2) the full and punctual performance within applicable grace periods of all other obligations of the Company whether for fees, expenses, indemnification or otherwise under the Indenture and the Notes. 

The obligations of the Guarantor to the Holders and to the Trustee pursuant to this Guarantee and the Indenture are expressly
set forth in Article 14 of the Indenture, and reference is hereby made to the Indenture for the precise terms and limitations of this Guarantee. Each Holder of the Notes to which this Guarantee is endorsed, by accepting such Notes, agrees to and
shall be bound by such provisions. 
 All terms used and not otherwise defined in this Guarantee which are defined in the
Indenture shall have the meanings assigned to them in the Indenture. 
 IN WITNESS WHEREOF, the Guarantor has caused this
Guarantee to be signed by a duly authorized officer. 
  

			
	DANAHER CORPORATION, as Guarantor
	
	By:                                   
                                     
	Authorized Signatory

  
 F-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00301-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00301-of-00352.parquet"}]]